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INTRODUCTION 
 
 
 
 
 
 
 
Patents are now an integral part of global economy. The creation of the 
world trade system has also redefined the value of intellectual property 
protection and generated an unprecedented demand for patent protection 
that is no longer l imited o the tradit ionally patent-oriented economies of 
Europe, Japan and the USA. 
Countries l ike China, India and Korea, and Singapore and Israel too, are 
just some of the new players heavily involved in patent-driven innovative 
competit ion. 
Patents protect technical inventions. An invention can, for example, be a 
product, process or apparatus. Inventions are only patentable if  they are 
novel, industrial ly applicable and involve an inventive step, but even then 
patent protection is not ranted automatically. The application must be 
accompanied by a ful l  technical description of the invention, which the 
Office then examines for compliance with the European Patent Convention. 
Patents give their owners the right to prevent others from using their 
invention, and are thus of major economic importance. They also help to 
recoup research costs, al lowing the inventor to reinvest in research and 
development.  
The publication requirement allows competitors to build on patented 
inventions and come up with even better technical solutions. In doing so, 
patents boost the innovation which Europe badly needs to keep up with 
other economies, and contribute to the further development of a knowledge 
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society. The 56 mil l ion or so patent documents contained in the public EPO 
database constitute a vast trove of technical information. 
The field of medical device, IPC class A61, according to European Patent 
Office Annual Report of 2005, is one of the technical f ields with the most 
f i l ings.  
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This state of the art investigation, performed using the patent publications 
database, is focused on the f ield of diagnostic ultrasound, a f ield that 
thanks to its non ionizing nature and low cost is a very high growing area 
and a lot of scientif ic research is made. 
Scope of this work is to provide an useful tool that al lows to check the level 
of the ultrasound technology and to indicate the future direction of this 
technique. 
Scope of this work is also to provide information to all the researchers and 
inventors who want to set out a patent procedure of an invention. As known, 
the patent procedure, from the fi l ing day unti l  the decision of granting the 
patent is quite expensive, this work could be used as a primary consultation 
tool before to present a patent application. All chapters of this work contains 
an introduction that explain the technical problematic of a f ield and in the 
subsequent sections the solutions are described.  
 
In the first chapter of this work the European Patent Office and the world of 
patents is introduced. A special attention is revolted to several art icles of 
the EPC (European Patent Convention) and to the classif ication system 
adopted by the EPO. Some statist ics about European patent application 
fi led in 2005 are il lustrated and the difference between the f irst to invent 
system adopted by EPO (and by the majority of countries) and the f irst to 
invent system (adopted by U.S.A.) wil l  be treated at the end of this chapter. 
In the second chapter  the basics of ultrasound are i l lustrated with 
particular attention to the physics principles that are at the base of 
ultrasound devices described in this state of the art investigation. 
The state of the art is divided in 5 chapters, from 3 to 7, each chapter is 
about a specif ic technique. In the third chapter  the ultrasound contrast 
agents are introduced and their main diagnostic application are disclosed. 
The fourth chapter  is about three dimensional imaging, this f ield is divided 
in 4 section: mechanical, free-hand, 2D arrays and catheters. 
In the fifth chapter  the technique of elastography and its application is 
described focusing on the stimulation protocols and methods. 
The sixth chapter  is directed to all the devices that al low to study the blood 
flow inside vessels and arteries and the seventh chapter treats about the 
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ultrasound catheters and their characteristics. At the end of each chapter 
statistics about the trends in European patent application in the last 25 
years wil l  be i l lustrated. 
In the conclusion of this work the future developments f ield of ultrasound 
technique wil l  be i l lustrated. 
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CHAPTER I 
THE EUROPEAN PATENT OFFICE  
& THE STATE OF THE ART 
 
 
 
The mission of the EPO 
– the patent granting authority for Europe –  
                                                                            is to support competitiveness and   
economic growth  
                                                                                               for the benefit of the citizens 
of Europe 
 
 
 
 
 
 
 
 
1.1 INTRODUCTION 
The European Patent Office (EPO) grants European patents for the 
contracting states to the European Patent Convention (EPC), which was 
signed in Munich on 5 October 1973 and entered into force on 7 October 
1977. It is one of the big three patent off ices (with USA and Japan) and it is 
the executive arm of the European Patent Organisation, an 
intergovernmental body set up under the EPC, whose members are the EPC 
contracting states. The contracting states are 31, in the course of the year 
2005, Latvia became the European Patent Organisation’s 31st member 
state. The contracting states of EPO are (Fig. 1.1): 
 10
 
 
 
Figure 1.1 The contracting states to the EPC   
 
The EPO is not an EU organization, and is wholly self f inancing. The 
activit ies of the EPO are supervised by the Organisation’s Administrative 
Council, composed of delegates from the contracting states  
In view of the increasing interest  in obtaining patent protection in central 
and eastern European countries, the European Patent Organisation has 
concluded bilateral agreements with Albania, Croatia, Lithuania and the 
former Yugoslav Republic of Macedonia, al lowing the protection conferred 
by a European patent to be extended to these countries at the applicant’s 
request. In October 1999 the EPO began negotiations to introduce a similar 
system for validating European patents outside Europe. 
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Figura 1.2: European Patent Office organigram 
 
The location of the European Patent Office and the staff are: 
•  MUNICH 
  
DG 3  
Boards of Appeal 
DG 4  
Administration 
DG 5  
Legal and Int. Affairs 
 
•  THE HAGUE 
 
DG 1 
Operations  
DG 2 
Operational Support 
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•  BERLIN 
 
DG 1 
Operations 
DG 2 
Operational Support 
•  VIENNA 
 
DG 4 
Patent information 
DG 2 
Operational Support 
 
•  EPO STAFF BY LOCATION 
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1.2 STRUCTURE OF AN EUROPEAN PATENT 
A patent is an exclusive entit lement to an invention and allows to forbid 
other people from using it for commercial purposes within a certain area of 
jurisdiction. 
A patents protect the inventor against others taking advantage of the 
invention without payment. 
The European Patent is divided in 3 parts 
•  Description 
•  Figures 
•  Claims 
The first page of a patent contains some FIELDS of a patent l ike the 
publication date, the inventor name, the t i t le etc. The layout of the f irst page 
is shown in f igure 1.3 
 
Figure 1.3 First page of a patent 
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The DESCRIPTION and the FIGURE are useful to understand the technical 
problem and the solution provided by the inventor.  
The most important part of a patent are the CLAIMS. The claims are in the 
last part of the patent after the description. 
 
Figure 1.4 Claims 
 
The protection of the patent is guaranteed ONLY on what is written on the 
claims.  
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1.3 IPC, THE INTERNATIONAL PATENT CLASSIFICATION 
The IPC is a worldwide patent classif ication system, which is elaborated and 
published under the responsibil i ty of WIPO (Geneva). 
The IPC was established init ial ly on request of the Council of Europe, The 
first edit ion was in force from September 1, 1968, to June 30, 1974. The 
second edit ion was in force from July 1, 1974 ti l l  December 31, 1979. Since 
then there is a new edit ion every 5 years. The actual edit ion (the 8th) is in 
force since January 1, 2005. 
The IPC has a hierarchical structure: 
SECTION        e.g.       A 
CLASS                        A01 
SUBCLASS                 A01B 
MAIN GROUP             A01B1/00 
SUBGROUP                A01B1/02 
The IPC is divided into eight sections, The section t it les are to be 
considered as a very broad indication of the content: they do not define the 
exact scope: 
A: HUMAN NECESSITIES 
B: PERFORMING OPERATIONS; TRANSPORTING 
C: CHEMISTRY; METALLURGY 
D: TEXTILES; PAPER 
E:  FIXED CONSTRUCTIONS 
F: MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; 
BLASTING 
G: PHYSICS 
H: ELECTRICITY 
 
As described above each section is divided into classes, A class symbol 
consists of the section symbol, followed by a two-digit number, as for 
example: 
 
A61              MEDICAL OR VETERINARY SCIENCE; HYGIENE 
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Classes  comprise one or more subclasses. The subclass symbols consist of 
the class symbols followed by a capital letter. 
 
A61B             DIAGNOSIS; SURGERY; IDENTIFICATION  
Subclasses  are broken down into main groups. Each main group symbol 
consists of the subclass symbol fol lowed by a one- to three-digit number, an 
oblige stroke and the number 00. 
 
A61B8/00          Diagnosis using ultrasonic, sonic or infrasonic waves             
 
Subgroups form subdivisions under the main groups. Each subgroup 
symbol consists of the subclass symbol fol lowed by the one- to three-digit 
number of i ts main group, the oblique stroke and a number of at least two 
digits other than 00. 
The subgroup tit le is often a complete expression, in which case it  begins 
with a capital letter. A subgroup tit le begins with a lower case letter i f  i t  
reads as a continuation of the t it le of the hierarchically higher group. The 
hierarchy among subgroups is determined solely by the number of dots 
preceding their t it les. 
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1.4 ECLA, THE EPO CLASSIFICATION 
Before 1968, the former “Institut International de Brevets” (IIB) used a 
classif ication system called “Indeling der Techniek” (IdT), developed by the 
Dutch Patent Office, and largely based on the “Deutsche 
Patentklassif ikation” (DPK). 
After the f irst edit ion of the International Patent Classif ication (IPC) had 
entered into force, the IIB decided to convert its search documentation from 
IdT to a system based on IPC. This classif ication system would later 
become the ECLA classif ication system. 
In view of the big differences between both systems, and in order to 
guarantee the quality of the system, it was decided to transfer the 
documents gradually, by “closing” the IdT at a certain date (different per 
technical f ield), and “opening” ECLA at the same time. New documents were 
from then on classif ied according to ECLA, the “backlog” being reclassif ied 
systematically or “ad hoc”, e.g. during searches. More than 95% of the 
classif ied documentation is now classif ied according to ECLA. Since 1991 
all the new documents are only classif ied according to ECLA. 
The structure of ECLA is similar to that of the IPC described in section x.2, IPC 
Guidance Headings are only used to identify parts of subclasses relating to 
the same subject matter. They do not define the scope of groups as such. 
Internal subgroups have the same symbol as an IPC group, the text of these 
internal subgroups is put between [N: ] .  
A61B8/00         Diagnosis using ultrasonic, sonic or infrasonic waves, 
( imaging of      
                        objects using sonar G01S15/00) 
A61B8/08         . Detecting organic movements or changes, e.g. tumours, 
cysts 
A61B8/08F       . . [N: using mammography (mammography by 
transil lumination,    
                           X-ray mammography; detection of breast cancer)] 
A61B8/08F2      . . .  [N: with suspended breasts, e.g. patient in prone 
posit ion]  
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1.5 THE STATE OF THE ART 
The state of the art is the highest level of development, as of a device, 
technique, or scientif ic f ield, achieved at a particular t ime. 
First used in 1910 and in the context of the European Patent Convention, 
the term "state of the art" is a very important concept in the process of 
assessing and asserting novelty  and inventive step ,  and is a synonym of the 
expression "prior art".  
Before to define the term "state of the art", the terms novelty and inventive 
steps should be defined. The ART 54 of the European patent convention 
establish that: 
Novelty, Art 54 of EPC 
(1)An invention shall be considered to be new if it  does not form part of the 
state of the art. 
(2)The state of the art shall be held to comprise everything made available 
to the public by means of a written or oral description, by use, or in any 
other way, before the date of f i l ing of the European patent application. 
(3) Addit ionally, the content of European patent applications as f i led, of 
which the dates of f i l ing are prior to the date referred to in paragraph 2 and 
which were published under Article 93 on or after that date, shall be 
considered as comprised in the state of the art.  
(4) Paragraph 3 shall be applied only in so far as a Contracting State 
designated in respect of the later application, was also designated in 
respect of the earl ier application as published. 
(5) The provisions of paragraphs 1 to 4 shall not exclude the patentabil ity of 
any substance or composit ion, comprised in the state of the art, for use in a 
method referred to in Article 52, paragraph 4, provided that i ts use for any 
method referred to in that paragraph is not comprised in the state of the art.  
 
Inventive step, Article 56 of EPC 
An invention shall be considered as involving an inventive step if, having 
regard to the state of the art, i t  is not obvious to a person skil led in the art. 
If  the state of the art also includes documents within the meaning of Article 
54, paragraph 3, these documents are not to be considered in deciding 
whether there has been an inventive step.  
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"The state of the art shall be held to comprise everything made available to 
the public by means of a written or oral  descript ion, by use, or in any other 
way, before the date of f i l ing of the European patent application" according 
to Art 54(2) EPC. Due account should be taken of Art. 54(3) as well, but 
merely for the examination of novelty. 
The expression "background art" is also used in certain legal provisions, has 
the same meaning. The expression "internal state of the art" is used to 
describe the state of the art merely on possession of the (patent) applicant, 
but not in the public domain. 
One of the most important art icles of the Convention, Article 52(1) EPC, 
entit led "Patentable inventions", states: 
"European patents shall be granted for  any inventions  
•  which are susceptible of industrial application 
•  which are new, and  which involve an inventive step  
 
This art icle constitutes the basic, central patentabil ity provision under the 
EPC. 
However, the EPC provides further indications on what is patentable, by 
introducing exceptions. There are exceptions by virtue of the nature of the 
patent system (Article 52(2) and (3)) and exceptions by virtue of 
policy(Articles 52(4) and 53). 
First, discoveries, scientif ic theories, mathematical methods, aesthetic 
creations, schemes, rules and methods for performing mental acts, playing 
games or doing business, programs for computers and presentations of 
information are not regarded as inventions and are excluded from 
patentabil i ty only to the extent that the invention relates to those areas as 
such.  These exceptions, by virtue of the nature of the patent system, have 
been introduced as a way to i l lustrate what cannot be patentable due to the 
nature of the patent system, i.e. a patentable subject-matter should usually 
be directed to some physical product or process. The European Patent 
Office interprets this as requiring that the features providing the inventive 
step must be outside those areas. 
The second set of exceptions, the exceptions by virtue of policy, include: 
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•  methods for treatment of the human or animal body by surgery or 
therapy, and diagnostic methods practiced on the human or 
animal body. 
•  inventions contrary to "order public" or morality 
•  plant or animal varieties and essential ly biological processes for the 
production of plants an animals. 
 
In patent law, industrial applicabil i ty or industrial application is a 
patentabil i ty requirement according to which a patent can only be granted 
for an invention which is susceptible of industrial application, i .e. for an 
invention which can be made or used in some kind of industry. In this 
context, the concept of "industry" is far-reaching: it includes indeed 
agriculture for instance. 
The industrial application requirement is closely related to the requirement 
of suff iciency of disclosure, in fact a patent application must disclose the 
invention in a manner suff iciently clear and complete for i t  to be carried out 
by a person skil led in the art. 
The uti l i ty in patent law, is a patentabil ity requirement. Today, the uti l i ty 
requirement is the lowest bar and is easily met. Largely uti l i ty is used to 
prevent the patenting of inoperative devices such as perpetual motion 
machines. 
European patent law does not test uti l ity. Instead, it  requires that to be 
patentable an invention must have industrial applicabil i ty. 
In most patent laws, prior art  or state of the art  is al l  information that has 
been made available to the public in any form before a given date. If an 
invention has been described in prior art, a patent on that invention is not 
valid. 
Information kept secret, for instance as a trade secret, is not usually prior 
art. Generally, this means that a patent wil l be granted on the invention 
despite the fact that someone else knew of the invention. A person who 
used an invention in secret may in some jurisdictions be able to claim "prior 
user rights" and thereby gain the right to continue using the invention. As a 
special exception, earl ier f i led and unpublished patent applications do 
qualify as prior art in certain circumstances. 
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The term "state of the art" is mainly used in the patent f ield. Patents 
disclose to society how an invention is practiced, in return for the right 
(during a l imited term) to exclude others from manufacturing, sell ing, 
offering for sale or using the patented invention without the patentee's 
permission. Patent off ices deal with prior art searches in the context of the 
patent granting procedure. To assess the validity of a patent application, 
patent off ices explore the prior art that was disclosed before the invention 
occurred (in the United States and all  f irst-to-invent patent systems) or 
before the f i l ing date (in Europe and all f irst-to-f i le patent systems). 
 
1.6 FIRST TO FILE  V.S FIRST TO INVENT PATENT SYSTEM 
First to file and first to invent are legal concepts that define who has the 
right to the grant of a patent for an invention. The first to f i le system is used 
in the majority of countries, with the notable exception of the United States, 
which operates a f irst to invent system. 
In a f irst to f i le system,  the right to the grant of a patent for a given 
invention l ies with the f irst person to f i le a patent application for protection 
of that invention, regardless of the date of actual invention. 
The United States uses a f irst-to-invent  system, unlike most other countries 
in the world. Invention is the U.S. generally defined to comprise two steps: 
(1) conception of the invention and (2) reduction to practice of the invention. 
When an inventor conceives of an invention and dil igently  reduces the 
invention to practice (by f i l ing a patent application, by practicing the 
invention, etc), the inventor's date of invention wil l  be the date of 
conception. Thus, provided an inventor is di l igent in reducing an application 
to practice, he or she wil l  be the f irst inventor and the inventor entit led to a 
patent, even if another f i les a patent application (reduces the invention to 
practice) before the inventor. 
However, the f irst applicant to f i le has the prima facie  r ight to the grant of a 
patent. Should a second patent application be f i led for the same invention, 
the second applicant can institute interference proceedings to determine 
who was the f irst inventor and thereby who is entit led to the grant of a 
patent. This can be an expensive and time-consuming process. 
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The debate as to which system is better is long-running and unlikely to 
reach a single conclusion. There are arguments for and against both 
systems. 
The first to file system leads to procedural certainty as the fi l ing date of an 
application can very rarely be challenged. In contrast, the f irst to invent 
system leads to uncertainty as the right to grant of a patent can be 
challenged by a second party and can only be f inally determined by 
extensive consideration of the making of the invention. 
It is said, however, that the f irst to f i le system favors large companies who 
can afford to rapidly f i le patent applications, thereby gaining an advantage 
over smaller companies who are slower to f i le due to cost restraints. The 
first to invent system is therefore said to be beneficial in encouraging the 
growth of smaller companies. A potential problem with this argument is that 
a smaller company, f i l ing second, would have to rely on interference 
proceedings to claim their patent, which may be beyond their economic 
reach and they are therefore no better off. 
Concluding this section we can cite the change made in 1989 by Canada, in 
fact they change from a f irst to invent system to a f irst to f i le invention 
priority system leaving U.S.A and Phil ippines as the only countries that 
continue to grant patents on the basis of a f irst to invent system. 
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1.7: HOW TO SEARCH A PATENT INTO DATABASE 
At EPO to perform the research of a patent it is possible to use the SEA 
(Search Examiners Application). 
Three tools in particular are particularly useful: 
•  Internal 
•  X-Full 
•  Viewer 
Internal is a tool that al lows to search in all  the f ields of a patent, in the t i t le 
and in the abstract.  
 
Figure 1.5 Snapshots from Internal 
 
X-Full is a tool that al lows to search in the whole text of a patent. The 
desired word (or words) is written in the QUERY field as shown in f igure 1.6 
 
 
Figure 1.6 Snapshots from XFull 
 
White X-Full i t  is possible to combine the results from internal with the 
desired query. 
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When the research is f inished and the desired patent or patents are 
individuated it  is possible to visualize them whit the VIEWER. 
After saving the results of the research in a working l ist is possible to 
visualize the results. 
 
Figure 1.7: Snapshot from VIEWER (Working List Selection) 
 
The patents are then displayed and it is possible to highlight some words in 
different colors that helps the user to individuate the most interest part of 
the patent and visualize all the images. 
 
Figure 1x.8: Snapshot from VIEWER  
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CHAPTER II 
ULTRASOUND OVERVIEW     
 
 
 
 
 
 
 
 
 
 
 
Introduction 
A typical medical ultrasound device sends ultrasound waves into the t issue 
and analyze the reflecting waves in order to obtain images of the region of 
interest or mechanical parameters of the t issue. 
 
2.1 TRANSDUCERS AND THEIR CONFIGURATIONS 
An ultrasound transducer generates acoustic waves by converting magnetic, 
thermal, and electrical energy into mechanical energy. The most eff icient 
technique for medical ultrasound uses the piezoelectric effect, which was 
first demonstrated in 1880 by Jacques and Pierre Curie [Curie and Curie, 
1880]. They applied a stress to a quartz crystal and detected an electrical 
potential across opposite faces of the material. The Curies also discovered 
the inverse piezoelectric effect by applying an electric f ield across the 
crystal to induce a mechanical deformation. In this manner, a piezoelectric 
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transducer converts an oscil lating electric signal into an acoustic wave, and 
vice versa. 
 
•  Material 
Ferroelectric materials strongly exhibit the piezoelectric effect, and they are 
ideal materials for medical ultrasound. For many years, the ferroelectr ic 
ceramic lead-zirconate-titanate (PZT) has been the standard transducer 
material for medical ultrasound. 
Recent evolution in material technology allows to combinine the PZT and 
epoxy in different ratios and spatial distributions to create Polyvinylidene 
dif luoride (PVDF). 
PVDF is a ferroelectric polymer that has been used effectively in high-
frequency transducers. 
 
•  Scanning with array transducers 
The arrangement of the transducers is a very important aspect of ultrasound 
devices. An important step for ultrasound technology was the development 
of l inear-array transducers. Previously, ultrasound systems had made an 
image by manually moving the transducer across the region of interest. 
Linear array transducers were designed to electronically steer and focus the 
beam  in a region of interest. 
First developed for radar, sonar, and radio astronomy after world war II, in 
the f irst part of ’70 they were is formed by a large number of piezoelectric 
elements arranged l ike in f igure 2.1. They can be activated at different t imes 
in order to obtain different wave-forms. 
 
 
Figure 2.1:  Linear Array  
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The possible piezoelectric elements configurations in l inear array are: 
 
•  Linear Sequential Arrays; 
•  Curvil inear or convex Arrays; 
•  Phased Arrays; 
•  2D Phased Arrays. 
 
In sequential l iner arrays the scanning l ines are directed perpendicular to 
the face of the transducer; the acoustic beam is focused but not steered as 
shown in f igure 2.2 
 
Figure 2.2 Linear Sequential  Array 
 
Curvil inear or convex arrays have a different shape than sequential l inear 
arrays, but they operate in the same manner. The scan l ines are directed 
perpendicular to the transducer face, the f ield of view is wider because of 
the convex shape 
 
Figure 2.3: Curvil inear Array Configuration 
 
In a phased array all the elements are used to transmit and receive each 
l ine of data. As shown in f igure 2.4 the scanner steers the ultrasound beam 
through a sector-shaped region in the azimuth plane. 
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Figure 2.4:  Phased array Configuration 
 
A 2D phased-array has a large number of elements in both the azimuth and 
elevation dimensions. Therefore, 2D arrays can focus and steer the acoustic 
beam in both dimensions. A 2D array can scan a pyramidal region in real 
t ime to produce a volumetric image. 
 
2.2 ULTRASONIC IMAGING MODALITIES 
There are 3 different imaging modalit ies in ultrasound 
•  A-Mode; 
•  M-Mode; 
•  B-Mode. 
In A-Mode  an ultrasound signal is send into the body and the backscattered 
signal is shown usually on oscil loscopes. This modality is now obsolete. 
 
Figure 2.5 A-Mode view 
www.ultrasound.net 
 
A single beam in an ultrasound scan can be used to produce an M-mode  
picture where movement of a structure such as a heart valve can be 
depicted in a wave-l ike manner. 
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Figure 2.6 M-Mode view  
www.ultrasound.net 
 
In B-Mode  the transducer is swept either mechanically or electronically over 
many directions to build up two-dimensional views (B-mode or 2D). 
 
 
Figure 2.7 B-Mode view  
www.ultrasound.net 
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2.3 DOPPLER EFFECT 
 
The Doppler effect is a change in the frequency of a wave, result ing from 
motion of the wave source or receiver or in the case of a reflected wave, 
motion of the reflector.  In medicine, Doppler US is used to detect and 
measure blood flow, and the major reflector is the red blood cell. The 
Doppler shift is dependent on the insonating frequency, the velocity of 
moving blood, and the angle between the sound beam and direction of 
moving blood, as expressed in the Doppler equation: 
 
 
The angle of incidence between the ultrasound beam and the estimated flow 
direction (parallel to the long axis of the vessel) is the Doppler angle. 
 
 
Figure 2.8 Doppler Angle 
 
Df is the Doppler shift frequency (the difference between transmitted and 
received frequencies), f  is the transmitted frequency, v is the blood velocity, 
c  is the speed of sound, and q  is the angle between the sound beam and the 
direction of moving blood. The equation can be rearranged to solve for 
blood velocity, and this is the value calculated by the Doppler US device: 
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Current ultrasonic imaging systems operate in a pulse-echo (PE) or 
continuous-wave (CW) intensity mapping mode. 
In continuous wave the ultrasound signal is continuously transmitted into the 
body, and the reflected energy is analyzed. The main l imitation of CW is that 
i t  is not possible to separate Doppler signals arising from different points 
along the transmitted ultrasound beam. With PE it is possible to overcome 
this l imitation. 
Range resolution in pulsed Doppler is achieved by transmitt ing a short burst 
of ultrasound. The backpropagation signal reaches the transducer after a 
delay (2t),  where t is  the t ime that the ultrasound wave needs to reach the 
sampling volume. Thus the sampling volume can be moved to different 
posit ions along the beam by altering this delay. 
Right now there are 2 different imaging modalit ies called Color Doppler and 
Power Doppler. In Color Doppler the shift of frequency is used for calculate 
the velocity, the direction of f low information extracted by the electronics 
from the sequence of returning echoes is included in the velocity images, 
normally red denote f low toward the transducer and blue away from the 
transducer (see figure 2.9a). 
In power Doppler the amplitude of the signal is analyzed in order to 
calculate the number of moving cells in the sample volume. Power Doppler 
images are relatively straightforward to interpret: the power level at each 
pixel is presented as 
a level of brightness. Since the power at each pixel is fair ly similar (see 
figure 2.9 b), the images have a uniform brightness except perhaps at 
vessel walls or in turbulent areas. The main attraction of Power Doppler 
Imaging is that i t  is a sensit ive technique which is good for depicting f low in 
small vessels, it  therefore gives more complete images of vascularity than 
Doppler Velocity Imaging [Mc Dicken et al 2002].  
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Figure 2.9 (a)  Colour Velocity Doppler image of blood f low 
in the left  ventricle,  (b) a Power Doppler image of blood f low in the left  ventricle.  
[Mc Dicken et  al  2002]  
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2.4 STATISTICS 
 
As cited in the introduction, the f ield of medical device, IPC class A61, is 
one of the technical f ields with the most f i l ings. In the top f i lers with the 
EPO we find companies that are involved in medical f ield e.g. Phil ips, 
Siemens, and General Electric etc.  
 
 
The majority of patents and patent applications consulted in this work can 
be found in the main group A61B8/00, Diagnosis using ultrasonic, sonic or 
infrasonic waves.  
The statistics of this chapter (and also of the other chapters) are directed 
only to EUROPEAN PATENT APPLICATION and the research is based on 
the publication date. The publication date of the patents is assumed to be 
the date that reflects best the t ime that a technology is available to the 
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public. The figures of 2006 maybe are underest imated because of the 
backlog in classif ication. 
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CHAPTER III  
PERFUSION WITH ULTRASOUND CONTRAST 
AGENTS (USCA) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.1 INTRODUCTION TO USCA 
Ultrasonic diagnostic imaging techniques enable imaging and measuring the 
anatomy and physiology within the body in a non-invasive manner. With the 
use of ultrasound contrast agents (USCA) it is possible to obtain addit ional 
information about perfusion in a minimally invasive way.  
These substances are introduced into the body to enhance ultrasonic 
diagnosis quality [Harvey et al. 2004].  They strongly interact with ultrasonic 
waves and are bio-compatible, so they have no or l i t t le side-effects for the 
patient  [Wei et al. 1997]. 
The first European patent application in this f ield was fi led in 1984, but, as 
it is discussed in the statist ics section, only in the last 6 years there has 
been a signif icant increase of patent applications. 
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An USCA is composed of t iny bubbles (called microbubbles) f i l led with air or 
other gas [Wei et al. 1997].  During a typical USCA investigation a 
suspension of microbubbles is infused into the patient body in a continuous 
manner or as a bolus. The microbubbles are 1-7 microns in diameter and 
they are capable of surviving the passage through the capil laries. 
The physics of the interaction between the USCA and the acoustic wave is 
very complex and it depends on a great number of parameters, including the 
type of gas inside the shell,  the material of the shell and the acoustic 
pressure of the ultrasonic wave. The following properties of USCAs are of 
particular interest in the context of ultrasound diagnosis: 
 
•  The high difference in acoustic impedance of the gas/fluid interface 
results in a strong response to the ultrasonic signal (High 
Echogenity); 
•  High intensity sound impulses destroy the bubbles with the result of a 
high-intensity broadband signal produced by their collapse [Harvey et 
al. 2004]; 
•  Air bubbles in the sound field reverberate and return sound with 
harmonic frequencies. This phenomenon can be used in "harmonic 
imaging" [L.Dalla Palma et al. 1999].  
 
 
Figure 3.1 interaction between US wave and microbubbles, http://www.mecheng.ucl.ac.uk 
 
Today a variety of contrast agents is available on the market. They differ by 
the type of gas and shell (stabil ization), table 3.2 summarises the most 
current ones. 
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Table 3.2: Most current ultrasound microbubbles [Harvey et  al .  2004] 
 
Blood is not very echogenic and perfusion images with good resolution and 
penetration are diff icult to obtain. This problem is overcome thanks to the 
high echogenity of the USCA that al lows tracking blood flow through vessels 
and organs with ultrasound transducers. 
•  SPECIAL WAVEFORM STIMULATION 
It is possible to further enhance the quality of the image by coupling the 
USCA with special waveform stimulation l ike pulse inversion, codec 
excitation or chirp waveform. 
In pulse inversion two signal 180° out of phase are sent to the t issue as 
shown in f igure x.3 
 
Figure 3.3: Pulse Inversion Stimulation (EP0913704) 
 
Due to the non l inearity of the t issue and microbubbles response the two 
received signals are not symmetric as the emitted pulses are. 
In fact odd-ordered harmonics (fundamental, 3rd, 5th etc.) remain 180° out 
of phase, whereas even-ordered harmonics (2nd, 4th, etc.) are in phase. 
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Figure 3.4: Odd-ordered harmonics and even-ordered harmonics (EP0913704) 
 
However, i t  must be remembered that ultrasonic imaging transducers have 
finite pass bands, so the array wil l  typically reproduce only the fundamental 
and the second harmonic; higher order harmonics wil l  be eliminated by the 
upper cut-off of the transducer.  
The two received echoes are processed by an adder: 
 
Figure 3.5: Elimination of the fundamental frequency components 
 
As a result of this combination, the fundamental frequency components, 
being of opposing phases or polarity wil l  cancel out. The second harmonic 
frequency components, being in phase, wil l  reinforce each other; so a 
second harmonic signal is produced. If a subtractor is used instead of the 
adder, the harmonic components wil l  cancel and the fundamental ( l inear) 
components wil l  reinforce each other to produce separated fundamental 
frequency components. 
 
Codec excitation has gained increasing attention in medical ultrasound 
over the last 10 years as a way of improving the SNR and consequently 
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increasing the observation depth and/or axial resolution (Chiao and 
Mao,2005). 
The physics and formation of codec excitation is relatively complex and is 
beyond the scope of the present study, only the basic principle wil l  be 
described. 
Codec excitation relies on transmitt ing, instead of a short Gaussian pulse as 
in the case of conventional ultrasound, a longer pulse train of higher energy, 
having a particular ("coded") modulation of frequency and/or phase. At 
reception this particular modulation is identif ied (i.e. decoded or 
compressed) with a (matched) f i lter which enables to recover the system 
response of the t issue. 
The codec excitation technique can also be combined with second harmonic 
imaging, thereby effectively cancell ing out the acoustic response of media 
having l inear response (Chiao and Mao,2005); and it has also been 
investigated for imaging with USCA (Boobson et al. 2005). 
 
Another way to enhance the bubble nonlinear response is to stimulate the 
microbubble with chirp waveform. The chirp waveform is a combination of : 
1. Low frequency wave that compress the bubble and init iate its dynamic 
(see f igure x.6,f irst wave component); 
2. High frequency wave (see figure x.6,second wave component) to 
produce an enhanced bubble nonlinear response 
 
Figure 3.6: Chirp Waveform (EP1406096)  
By adjusting the centre frequency, amplitude, and bandwidth for the two 
wave components of the stepped-chirp waveform and their relative phase, 
frequency, switch t ime (the t ime point where the waveform changes from 
one frequency to another) and the t ime delays in between, the nonlinear 
response of the bubble is enhanced. 
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3.2 USCA TECHNOLOGY AND APPLICATION IN LOW MECHANICAL 
INDEX IMAGING 
This part addresses patents and patent applications directed to Low 
Mechanical Index (MI) imaging with USCA. The previously addressed 
characteristics of USCA, harmonic effect, high echogenity, can be exploited 
without breaking the microbubbles.  
 
•  BLOOD DYNAMICS INVESTIGATIONS 
As already observed Blood without USCA has a very low echogenity so it is 
very diff icult to obtain information about blood flow with ultrasound. USCAs 
are very useful for this purpose, since their high echogenity allows to obtain 
a stronger signal from the blood vessels. 
As shown in several patent applications as for example US2004087858  the 
contrast-to-t issue ratio (see glossary for the definit ion) is improved while the 
contrast agent is continuously infused.  
To distinguish the blood flow from the surrounding t issue it is possible to 
perform subtraction imaging as shown in patent application US2002028994 
where two images of the same region of interest are acquired before and 
during USCA infusion and then subtracted raster by raster (A Raster defines 
values for pixels occupying a particular rectangular area of the plane) to 
discriminate the blood flow from the surrounding tissue. 
USCA can be used to perform Power Colour Doppler imaging  
(US2001009977) .  The microbubbles are used to improve the distance 
resolution, sensit ivity, and increase the frame rate in power Doppler. 
Similar imaging protocol, i .e. injection of a bolus (or continuously) of  USCA 
and imaging how it f lows through the vessels, can be implemented with 
special waveforms such as chirp wave-form as explained in patent 
application EP1406096.  
 
•  TISSUE ABLATION VISUALIZATION 
Cardiac arrhythmia is a group of condit ions in which the contraction of the 
heart is irregular or is faster or slower than normal. This pathology is 
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caused by  electrical impulses that do not correctly spread trough 
myocardium causing the irregular contraction.  
A therapy provide to locate the source of an abnormal electrical activity and 
isolate this  source from the coronary vessels (Ablation). 
Successful treatment of cardiac arrhythmia requires that the ablation lesion 
have a suff icient extent and depth in the myocardium to effectively eliminate 
the source of the abnormal electrical activity associated with the arrhythmia. 
A contrast agent is injected into an artery that feeds blood to t issue 
surrounding an ablation lesion (US2003208123).  During and after contrast 
agent injection, the ablat ion lesion and surrounding tissue is imaged. 
 
 
Figure 3.7 Echocardiogram A: ground level, B: after inj. of 1 ml of Levovist (350 mg/ml)  
 
The open capil laries in the l iving t issue allow the contrast agent to perfuse 
therein, while the closed capil laries in the nonviable t issue of the ablated 
lesion prevent the contrast agent from perfusing therein therefore it  is 
possible to discriminate the l iving t issue from the ablated one and visualize 
the extent and depth of ablation lesions and decide whether the treatment is 
successful or not. 
 
 
 
 
 
 
•  DIAGNOSTIC IMAGING FOR DETECTING LESIONS OF THE LIVER 
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Blood flow to the l iver comes from two sources: the hepatic artery and the 
portal vein. The l iver receives 20% of i ts total supply of blood from the aorta 
and hepatic artery and 80% of its blood supply from the inferior vena cava 
and the portal vein. So is possible from literature and medical investigation 
to establish a curve that describes l iver perfusion for normal patients. 
It has been found that the vasculature developed by a tumour l ike  
hepatocellular carcinoma (HCC) is supplied primarily from the hepatic 
artery. Because the contrast agent f irst appears in the l iver by way of the 
hepatic artery, this means that one of the init ial sites of contrast agent 
detection in the l iver after a bolus inject ion is the locus of an HCC lesion. If  
no lesion is present, only the usual hepatic artery and normal vessels 
supplied by it wil l  appear with contrast present. 
 
Figure 3.8: Normal and pathologic curve (WO2006090309) 
 
As explained above most of the f low of blood with contrast agent in the 
normal l iver is delayed because its passage through the kidneys. If a bolus 
of USCA is injected at t0, it reaches the l iver at a t ime t2 (see f igure 3.8). 
However the f low of blood with contrast agent in the hepatic artery and into 
the vasculature developed around an HCC lesion wil l  appear earl ier (t1<t2 
as shown in f igure 3.8). It  is therefore the function of a pixel classif ier   to 
identify pixel or voxel data which is characteristic of the cross-hatched area 
between curves registered with the USCA and the normal statistical curve  
(WO2006090309) 
 
 
 
 
 
•  ULTRASOUND COMPARISON IMAGES 
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Tumours develop a complex vascularisation. Treatment of tumours involve 
destruction of their  vascularisation, e.g.  radiotherapy or chemotherapy. 
Successful treatment requires that the whole area affected by the tumour is 
isolated. A contrast agent is injected into the region of interest before and 
after treatment and its f low is observed with an ultrasound scanner 
(US2005187475).  I f  the treatment is successful the contrast agent is 
prevented from flowing into the tumour through the vessels l ike shown in 
f igure 3.9 
 
 
Figure 3.9: Pre and post treatment images US2005187475  
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3.3 USCA TECHNOLOGY AND APPLICATION IN HIGH MECHANICAL 
INDEX IMAGING 
 
This part addresses patents and patent applications directed to High 
Mechanical Index (MI) imaging with USCA, i.e. involving the destruction of 
bubbles with a high intensity ultrasound wave. The destruction of USCA can 
be exploited in order to obtain a stronger backward signal and higher 
brightness in the image (f igure 3.10) as explained in patent US6245019. 
 
Figure 3.10: Comparison between High MI imaging and Low MI imaging  (US6245019)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
•  REFILLING IMAGES OF A VESSEL OR ORGAN 
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The basic principle of perfusion studies with USCA is to have a continuous 
injection of USCA,  destroy the agent in the area of interest (ROI) with an 
high mechanical index wave and see how it refi l ls.  
The refi l l ing rate can be used to quantify the blood flow and this rate can be 
obtained by computing the intensity of the backscatter signal  through time 
from the moment of transmitt ing the High MI pulse(EP1514516).  The blood 
flow is obtained by calculating the parameter  (see f igure x.11)   
 
Figure 3.11: Time Intensity curve (EP1514516)  
 
 
A similar protocol, i .e. transmitt ing an High MI pulse and subsequently 
imaging the refi l l ing at regular intervals can be implemented with specif ic 
imaging approaches, such as pulse inversion (EP0913704 & US6454714) or 
codec excitation (US2001044278) .  
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•  METHOD FOR MEASURING REAL TIME PRESSURE & FLUID 
DYNAMIC INSIDE MICROVESSELS 
When insonifying a population of microbubbles with a pulse of a given power 
a certain amount of them is disrupted depending on the acoustic pressure of 
the pulse and their size. 
It is possible to exploit the mechanical characterist ics of USCA for real t ime 
measurement of the pressure in a region of interest (WO0057792).  The f irst 
step for this procedure is to introduce into a cavity a composit ion of 
microbubbles with a variety of diameters corresponding to predetermined 
fragil i ty thresholds. Bigger microbubbles are more instable than the smaller 
ones. 
After a pulse of a given pressure some microbubbles collapse and from the 
ultrasound backscatter response we can determinate the population of intact 
and fail ing microbubbles in the region of interest and the intensity of this 
signal is inversely proportional to the internal pressure.  
By selectively destructing of microbubbles of a particular size range it is 
also possible to investigate the dynamic in small vessels (EP1354555).  
In fact with sequential ly transmitt ing pulses of increasing intensity it is 
possible to destroy selectively a fraction of bubbles (f irst the bigger, than 
the smaller) and observe how the smaller microbubbles f low into small 
cavity that bigger microbubbles can not reach.  
 
Figure 3.12 Stimulation protocol (EP1354555)  
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3.4 STATISTICS 
In the f ield of USCA about 110 European patent application have been found 
(see annex for the search procedure) .  The majority of these patent 
applications are classif ied as A61B8/00D:  
 
"Diagnosis using ultrasonic, sonic or infrasonic waves by tracers, e.g. 
microbubbles introduced into the bloodstream" 
 
As mentioned in the introduction, the f irst European patent application in 
this f ield was from 1984 (EP0072330, FUJITSU LTD, f i l ing date 
06.08.1984,addressing  pressure measuring with ultrasonic waves,) .  Since 
then this technique has been used in several other applications. In the 
successive years, especially from the beginning of nineties, an increase of 
patent applications in this f ield it 's observed. 
 
 
Figure 3.13: Trends in European Patent Application in USCA field 
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CHAPTER IV 
THREE DIMENSIONAL ULTRASOUND 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.1 INTRODUCTION 
In the last 10 years of research, investigators and commercial companies 
have advanced ultrasound imaging with the development of 3D ultrasound. 
The major reason for the increase in the use of 3D ultrasound is related to 
the l imitation of 2D viewing of 3D anatomy using conventional ultrasound. 
As observed in [Fenster et al. 2000] mentally combine 2D images by the 
operator to form an impression of 3D volume is a sub-optimal approach 
because: 
 
•  This approach is variable and subjective, i t  may lead to incorrect 
decisions in diagnosis and in the planning of the therapy; 
•  Diagnostic and therapeutic decisions often require an accurate 
estimation of organ or tumour volume, in conventional 2D ultrasound 
the volume is calculated by measuring height width and length in 2 
views and assuming an idealized (e.g. el l ipsoidal) shape. This method 
is variable and operator dependent; 
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•  I t  is diff icult to adjust the transducer in the same posit ion of a previous 
examination for monitoring therapeutic procedures; 
•  Some 2D slices of an organ are impossible to achieve because of the 
restriction imposed by the patient anatomy, but they can be 
reconstructed from a volume of data. 
 
In 3D ultrasound examination, 2D ultrasound images are combined by a 
computer to form an objective 3D image of the anatomy or pathology. This 
image can be manipulated and viewed by the physician to obtain views of 
the organ at any angle. 
Moreover, unlike CT and MR imaging, in which 2D images are usually 
acquired at a slow rate as a stack of parallel sl ices, in a f ixed orientation, 
ultrasound provides tomographic 2D images at a high rate (15–60 
images/Sec), and in arbitrary orientations [Gee et al.2003].   
In 1974, Greenleaf et al. f irst published a technique called "Ultrasound 
Computed Tomography" (UCT) describing an acquisit ion and reconstruction 
technique for volumetric echography. Success with this modality was l imited 
due to the l imited availabil i ty of computational power in the 1970s. 
Progress has been slow due to the enormous computational requirements 
which must be met in order to acquire, reconstruct and view 3D information 
in near real t ime on low-cost systems. Advances in computer technology and 
visualization techniques in the past few years have made 3D ultrasound 
imaging viable. 
 
4.2 3D ACQUISITION PROTOCOLS, SCANNIG TECHNIQUE AND IMAGE 
RECONSTRUCTION 
Most 3D ultrasound imaging systems make use of conventional 1D 
ultrasound transducers to acquire a series of 2D ultrasound images, and 
differ only in the method used to determine the posit ion and orientation of 
these 2D images within the 3D image volume being examined. The 
production of 3D images without distort ions requires that three factors be 
optimized  [Gee et al.2003]: 
•  Fast scanning procedure in order to prevent artefacts caused by 
involuntary, respiratory or cardiac motion 
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•  2D images posit ion must be known 
•  The apparatus must be simple and convenient to use 
In the majority of systems, 3D ultrasound is acquired by sweeping a 2D 
imaging plane over the area of interest and stacking up the result ing B-
scans to form a 3D volume. Figure x.1 shows the complete spectrum of 
possible approaches and the applications where the advantages of 3D 
ultrasound may be useful exploited. 
 
Figure 4.1: Ultrasound acquisition protocoles  [Gee et al. 2003] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 51
Four different 3D ultrasound imaging approaches have been pursued (f ig 
4.2) :  
•  mechanical scanners; 
•  free-hand techniques with posit ion sensing; 
•  free-hand techniques without posit ion sensing (only in chatters); 
•  2D array. 
 
 
Figure 4.2: Summary of 3D scanning methods (Fenster et al. 2000) 
 
 
 
Image reconstruction refers to the process of generating a 3D 
representation of the anatomy by placing the acquired 2D images in their 
correct relative posit ions and orientations in the 3D image volume, and then 
using their pixel values to determine the voxel values in the 3D image.  
Two methods have been implemented [Fenster et al. 2000]:  
•  Feature based reconstruction: The anatomical structures are 
determined  in the 2D slices and then reconstructed in 3D images 
•  Volume based reconstruction: Each pixel of a 2D slice is placed in its 
correct 3D coordinates, f irst two coordinates based on the 2D 
coordinates and the third coordinate based on the posit ion and 
orientation of the sl ice.  
As observed in the introduction of this work, discussion of the reconstruction 
of techniques is beyond the scope of the present study. 
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4.3 MECHANICAL SCANNERS 
In this approach the anatomy is scanned by using a motorized mechanical 
apparatus to translate, t i l t  or rotate a conventional transducer as it rapidly 
acquires a series of 2D ultrasound images spanning the volume of interest. 
Because the scanning protocol is predefined, the relative motion and 
orientation of each 2D image can be known accurately. The 2D images 
acquired during the scan are send to the computer and used to reconstruct 
3D volume. 
An application of this technique is breast tomography because the breast is 
immobile (so the t ime to translate or rotate the transducer is not a 
restriction), easy to access and homogenous. 
Good acoustic coupling between the transducer and the body must be 
ensured at any t ime during the rapid, cyclic movement of the probe. This 
issue is conventionally solved by using a coupling f luid (e.g. gel). To 
perform ultrasound breast tomography the female subject has to suspend 
one of her breasts into a container f i l led with acoustical coupling.  
The scanner placed into the housing rotates and translates while it acquires 
tomographic images (US200464046, US2004068180 US20060173307, 
WO2005087110, US200609693, US 200468180).  
 
Figure 4.3 Mechanical Scanner for breast 3D imaging (US20060173307 and US200609693) 
 
In f igure x.3 two methods are shown, the device in the left side 
(US20060173307)  The transducers array is mounted in a housing that can 
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be mechanically rotated in several direction(see fig. 4.3,letter a,b,c and 
number 40)in order to acquire 2D scans of the entire volume. 
The device in the right side of f igure 4.3 (US200609693)  comprises a 
chamber f i l led with coupling f luid with the transducer mounted inside. Also 
in this device a system allows transducers to rotate and translate around the 
breast. The patient in this case has to l ie in the prone posit ion in a special 
bed. 
The rotation of the ultrasonic transducer around the breast can cause 
turbulences in the coupling f luid and this can cause distortion in the 
tomographic image. This problem is solved using 2 chambers, one 
stationary in which the breast is immersed and one movable containing the 
transducers  (US2004064046) 
 
 
Figure 4.4: Double Chamber Device  (US2004064046) 
 
The fluid during the scan has the possibil i ty to f low from the movable to the 
stationary chamber. The communication between the 2 chambers reduces 
turbulences during the scanning process. To perform a tomographic scan of 
the breast the rotating chamber (in which the transducers are mounted) is 
rotated and a f irst 2D slice is created then the rotating chamber is 
incrementally lowered and another sl ice is acquired  (Fig. 4.5)  
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Figure 4.5 Acquisition of a volume  (US2004064046) 
 
 
When all the region of interest is scanned the 2D slices are processed by 
the computer and the 3D volume is created. 
Some of these devices can also be coupled with an invasive therapeutic or 
diagnostic procedure (WO200607423) involving a needle localized with 
ultrasound which can be used for inject ing drug (e.g. chemotherapeutic 
agent) into a tumour or used for biopsy (US200609693) .  
 
Figure 4.6: Mechanical Scanner coupled with needle  (US200609693)  
 
 
The time necessary for the mechanical movements required for the scan are 
a physical l imitation for this kind of devices, hence only static t issue without 
cyclic artefacts can be scanned with the scanners described above. To 
avoid this l imitation and obtain 3D image sets of moving organs the image 
can be acquired with an ECG gated device (DE19723053 and US5871019) .  
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As is well known the ECG is a record of the electrical activity of the heart. 
the so callad "R-Peak" correspond to the maximum of the electrical activity 
during the contraction of the ventricles and is easily discernible on the ECG( 
see figure 4.7)  Each 2D slice is acquired at the same period of the cardiac 
cycle and then reconstructed to create the 3D volume of the heart 
 
Figure 4.7: ECG - gated scanning procedure 
 
Mechanical scanners have also several applications in the IVUS (intra-
vascular ultrasound) and are described in the section 4.6. 
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4.4 FREE HAND SCANNERS  
The mechanical scanning allows to obtain relatively short imaging t imes, 
high-quality 3D images and fast reconstruction t imes. However, the 
bulkiness and weight of the scanning 
apparatus sometimes make it inconvenient to use, and large structures are 
diff icult to scan. To overcome this problem, free-hand scanning techniques 
that do not require a motorized f ixture have been developed by many 
investigators [Fenster et al. 2000].  
In these approaches, a sensor is attached to the transducer to measure its 
posit ion and orientat ion. While the transducer is being manipulated, the 
acquired 2D images are stored by a computer together with their posit ions 
and orientations. This information is then used to reconstruct the 3D image. 
However the operator must ensure that the sets of 2D images have no 
signif icant gaps. 
 
•  Free hand with articulated arm 
Position and orientation sensing can be achieved by mounting the 
ultrasound transducer on a multiple-jointed mechanical arm system.  
Potentiometers located at the joints of the arm provide the information 
necessary to calculate the relative posit ion and orientation of the acquired 
2D images (US5806521). 
 
Figure 4.8 Free Hand with articulated arm (US5806521) 
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•  Free hand with magnetic field sensors 
 
Magnetic f ield sensor can be used do determine the posit ion of the 
transducer. The transmitter is placed beside the patient and the receiver is 
mounted on the hand-held transducer (US6775404, EP0487339). The 
posit ion is calculated based on the received magnetic f ield  
The main problem with magnetic f ield sensors are interference from sources 
such as CRT monitors, ac power cables and electrical signals from the 
transducer itself which can compromise the tracking accuracy.  
 
•  Free hand with optical sensors 
To prevent artefacts induced by the environment optical sensor can be used 
as shown in patent application US2004167402.  The basic principle is the 
same as in an optical mouse of the computer. 
 
 
Figure 4.9: Free Hand Transducer with optical sensors  (US2004167402) 
 
The optical sensor allows to measure relative movement of the transducer 
over the skin and the signals from the sensor are used to determine the 
relative posit ion of each image. 
 
 
•  Free Hand with optical fibre 
A new technology that shows promising results in the area of 3D imaging is 
an optical system where optical f ibres are run through the machine 
[Pagulatos et al. 2005] 
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The spatial localizer consists of a f lexible tape with optical f ibre  sensors 
along its length. The curvature along the cable is measured using the 
optical f ibres and integrated to give the location and orientation of the 
probe. 
 
Figure 4.10 Free Hand system with optical fibre [Pagulatos et al .  2005]  
 
The posit ion tracking is insensit ive to the scanning environment, the main 
l imitation of this technique is that the location and orientation of the probe 
with practically long cable is not yet suff iciently accurate. 
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•  Free hand with speckle decorrelation 
An alternative technique, not requir ing any device, uses the acquired 
images themselves to extract their relative posit ions. This can be 
accomplished using the phenomenon of speckle decorrelation.  If two 
images are acquired from the same location, then the speckle pattern wil l  be 
the same, so that there wil l  be no decorrelation. However, if one of the 
images is moved with respect to the f irst, then the degree of decorrelation 
wil l  be proportional to the distance moved, the exact relationship depending 
on the beam width in the direction of the motion (US20030114755)  
This technique is used in obstetrics imaging to quantify volume and weight 
of the foetal and have some images of the foetal aspect. The accuracy of 
this technique is not very high and the effort required to obtain high quality 
3D ultrasound images often overweight the potential benefits [Fenster et al. 
2000].  
 
 
Figure 4.11 3D images of foetal 
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4.5 2D ARRAYS 
The mechanical and free-hand scanning approaches for 3D ultrasound 
images described in the paragraph 4.3 and 4.4 all involve acquiring 2D 
ultrasound images with a conventional transducer (1D array). 
The l imitations of the 1D array described above are: 
•  Low acquisit ion speed (e.g. mechanical movement); 
•  Low accuracy (e.g. free hand with speckle decorrelation); 
•  Relative movement between probe and patient. 
To overcome these l imitations 2D array have been developed in the recent 
years. A 2D phased array is formed by a large number of ultrasound 
piezoelectric transducers steered electronically in order to insonify a 
pyramidal volume of interest.  
With 2D array there are no moving parts and the acquisit ion of a pyramidal 
volume is almost instantaneous [Fenster et al. 2000]. There is no relative 
movement between the probe and the patient and the image accuracy is 
high. 
 
Figure 4.12 2D arrays (EP1242991) 
 
The main problem of 2D arrays is the large number of piezoelectric elements 
that has to be steered at the same time in order to create  the pyramidal 
beam. All the information from each piezoelectric element has to be send to 
the analyzing processor so there is also the problem of cables for 
connecting the array to the computer. These problems are reflected in high 
costs and so their commercial availabil i ty is yet l imited [Fenster et al 2006]. 
A 2D array is showed in patent application EP1242991. The array described 
is formed by more than 3000 transducers arranged in a dodecahedral shape 
as shown in f igure 4.13 
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Figure 4.13: 2D array EP1242991 
 
The transducers in the central part of the array (about 750) create the 
pyramidal beam, the others are used only for the received echo. 
Since a cable with more than three thousand conductors is not currently 
practical,  
(Such a cable would be impractically large, bulky and inflexible) the array is 
arranged in groups of 12 transducers. This reduces the number of 
conductors to 256.  
For every transducer a complex microelectronics is dedicated  as shown in 
f igure 4.14 
 
Figure  4.14: Microelectronics under each transducer EP1242991  
 
This microelectronics allows to rapidly elaborate the signal for each group of 
12 transducer and send the result ing signal to the analysing processor. 
Other sub-array arrangement and division aiming at the reduction of the 
bulkiness of the device are shown in patent  US6013032  and patent 
application , US20060106307 and US2003220569.  
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4.6 3D ULTRASOUND CATHETERS  
Due to the miniaturization of ultrasound transducer, the harmless character 
of an echographic acquisit ion as well as a very good resolution obtained at 
high frequencies, ultrasound has become a technique of choice in 
endovascular imaging or intra-vascular ultrasound (IVUS). 
This f ield has benefited from the advances in 3D ultrasound imaging, and 
catheters offering 3D ultrasound acquisit ion have been developed since the 
middle of the 90's.  
The techniques used in the f ield of 3D IVUS follow a similar pattern as in 
conventional 3D echography addressed in the previous section with some 
particularit ies related to the specif ic application. Catheters for 3D imaging 
can be classif ied in 3 categories: 
•  Mechanical; 
•  Free-Hand; 
•  2D array. 
The mechanical approach involves sweeping or rotating the 1D array with a 
motorized system (e.g. an electrical motor). An example of 1D phased array 
rotated in order to cover a 3D volume is described in patent application 
WO9856296  
 
 
Figure 4.15 Catheter with mechanical rotating phased array WO9856296  
 
 
The rotating  array showed in f igure 4.15 produces a sets of 2D images from 
which a 3D volume is reconstructed (f ig 4.16). The guide-wire guides the 
catheter to the desired destination. 
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Figure 4.16 2D slices WO9856296  
 
Patent application WO9856296  describes in addiction a channel for 
delivering USCA (see figure 4.16). As indicated in  Forsberg et al 2002   
delivering USCAs into the f ield of view of the ultrasound transducer allows 
to obtain f low information from smaller vessels associated with tumours .  
Another possible arrangement for the array is described in patent 
application US2003229286.  The transducers are disposed on the entire 
circumference of the catheter as shown in f igure 4.17 
 
Figure 4.17: Cross section of the catheter (US2003229286)  
 
1D array transducers are arranged in cluster, during imaging each cluster is 
t i l ted (over 60° or 90°) to cover a pyramidal volume. 
 
Figure 4.18: Scanning volume of a cluster with 60° tilt (US2003229286)  
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The integration of al l  the contributions of each cluster al lows to have a 
whole volume image as shown in f igure x.19 
 
Figure 4.19: Scanning volume obtained from integration of all cluster with 60° tilt (right) and 90° (left) 
(US2003229286)  
 
As described in section 4.3, also in catheters with mechanical scanners the 
images are hampered by cyclic artefacts. A solution is proposed in patent 
application WO9811823  where ECG-Gated 3D IVUS Image Acquisit ion is 
described. In the present application 360° IVUS images are acquired 
immediately after consecutive R-peaks. however in order to avoid distort ions 
caused by abnormal cardiac cycles, an image is rejected if the R-R interval 
does not meet a  predefined range. After each accepted 360° acquisit ion the 
catheter is pulled to its next posit ion for the acquisit ion of the next image.  
 
Figure 4.20 ECG-Gated IVUS acquisition [Van Bingelen et al. 1997] 
 
With this catheter i t  is possible to image the coronary arteries without 
imaging artefacts produced by cyclic changes in vascular dimension. 
 
Figure 4.21 ECG-Gated IVUS investigation of coronary arteries WO9811823  
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A system for free hand IVUS for 3D imaging of a target organ is described in 
patent application EP1717758 .  The catheter comprises a 1D phased array, a 
magnetic f ield posit ion sensor and an electrode that can be used to map the 
electrical activity of the heart. 
 
 
Figure 4.22: Free hand Catheter EP1717758  
 
The 1D array acquires 2D images of the target organ and sends them to the 
image processor unit with location and orientation coordinates. The catheter 
is then translate or rotated manually by the physician in order to obtain a set 
of 2D images of the volume of interest without gaps. 
Free hand IVUS 3D imaging is also possible without posit ion sensing, but 
the catheter must be pulled at constant velocity by the physician so each 2D 
slice is separated from the next one by the same distance.  
The advantages of 2D arrays in 3D imaging described in the previous 
section can also be exploited in catheters. Microelectronics and 
miniaturization of piezoelectric elements has allowed the use of 2D array 
also in IVUS. These devices offer the possibil i ty of real t ime 3D intra 
vascular imaging of moving organs e.g. heart [Light et al. 2001]  with high 
axial resolution (with catheters deep penetration is not required so higher 
frequencies can be used as observed in chapter 7.1). 
In patent applications US200328107  and US2005119572 a 2D array catheter 
is described. As for 2D arrays described in section x.5 the main problem to 
resolve is the number of piezoelectr ic element that have to be connected 
and steered at the same time. The solution described is similar to the one 
proposed in patent application EP1242991 (chapter 4.5), a sub-array 
division is made and each subarray has a dedicated microelectronic circuit 
to compute the signal received and to send information to the main 
computing system. 
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Figure 4.23: Pyramidal Beam produced  by the 2D array  (US2005119572 right)  (US200328107 
left)  
 
The handiness of the transducer is also an important characteristic. The 
catheter described in patent application US200328107  is equipped with a 
f lexible region that al lows to drive the catheter and to adapt the field of view 
to the region of interest. 
 
 
Figure 4.24: Flexible region of the catheter (US200328107)  
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4.7 STATISTICS 
Patents about this f ield can be founded in the following classes: 
A61B8/13          .     Tomography  
A61B8/14          . .    Echo-tomography 
A61B8/15          . .    Transmission-tomography 
And using the fol lowing key word: 
Z61B8 imaging three dimensional 
 
Figure 4.25: European Patent Application in three dimensional imaging with ultrasound 
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CHAPTER V 
ELASTOGRAPHY 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.1 INTRODUCTION 
It has been proved that pathological condit ions often produce changes in 
biological t issue stiffness. The different mechanical characteristic of the 
tumour's t issue from the surrounding tissue is the basic principle of 
palpation [Krouskop et al 1998]. 
However, a lesion, in the prostate or in the breast in particular, may or may 
not possess echogenic properties and it would be diff icult to detect it  with 
conventional diagnostic ultrasound imaging systems[B.S. Garra et al. 1997]. 
As the echogenity and the stif fness of t issue are in general uncorrelated, 
Garra et al. observe it is expected that imaging the mechanical properties of 
the biological t issue wil l  provide new information related to the pathological 
condit ions, facil itating the diagnosis process. 
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The imaging modality that facil i tates the display of mechanical properties of 
biological t issue is called elastography and is a sort of evolution of the 
palpation technique. 
 The purpose of elastography is to display an image of the distribution of a 
physical parameter related to the mechanical properties of the t issue for 
cl inical applications. 
The general principle of ultrasound elastography involves the fol lowing 
steps: 
1. Acquiring a pre-compression ultrasound image of the region of 
interest; 
2. Applying compression to the t issue; 
3. Acquiring a post-compression image of the same region; 
4. Evaluating the mechanical and elastic properties of the same region 
by comparing the pre and post-compression images (or signals), 
usually with correlation techniques. 
Ultrasound is a common imaging modality for this method because it is non-
invasive, safe (Radiofrequencies RF are non-ionizing radiation), inexpensive 
and portable.  
Elasticity imaging applications can be divided into 3 categories depending 
on the nature of t issue stimulation: 
•  Mechanical st imulation; 
•  Wave stimulation; 
•  Physiologic stimulation. 
 
5.2 SIGNAL PROCESSING 
Strain is defined as the deformation of an object normalized to its original 
shape. In a one-dimensional (1D) object ( i .e. an infinitesimally thin bar), the 
only possible deformation of the object is lengthening or shortening. This is 
i l lustrated in Figure 1(a). The relative amount of deformation is defined as 
strain. Strain, for which the symbol ε is used, can thus be written as: 
 
With L the length of the object after deformation and L0 its original length. 
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When the length of the object is not only known before and after 
deformation but also during the deformation process, the Lagrangian (or 
Instantaneous strain) strain can be defined: 
 
With L  (t) the length of the object at t ime instance t  and L  (t0)  =L0 its init ial 
length.  
 
Strain rate is the speed at which deformation (i.e. strain) occurs. It is 
represented by the symbol ε '   and has the unit 1/s.  Although the unit is in 
fact the same as Hz, i t  is preferable to use s-1  since Hz is normally used to 
express a periodic change. Clearly, in the most general situation, strain 
(and thus strain rate) does not necessari ly have a cyclic nature, as one can 
only deform an object once (D'Hooge et al. 2000). The instantaneous natural 
strain rate can be calculated as: 
 
With L ' (t) the rate of deformation and L  ( t) the instantaneous length of the 
object. 
A method for quantifying the strain and the strain rate is the Cross 
Correlation Method .  In this technique a RF signal l ine is acquired before and 
after deformation of an object.  
 
Figure 5.1: Cross correlation method 
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The regional motion is estimated by tracking a local radio frequent signal-
pattern (result ing from a specif ic distribution of scatterers)  between two 
subsequent acquisit ions by means of the cross-correlation function, which is 
a measure for the similarity of two signals as a function of their relative 
phase. 
Then the strain is obtained by dividing by the init ial length (L1).The strain 
rate can be obtained by calculating the temporal derivative of the strain . 
 
Figure 5.2 Schematic overview of operations in cross-correlation method 
 
Strain rate can also be expressed  as the difference in velocit ies at both 
ends of an object of init ial length L1, this is the base of the Velocity 
gradient method.  In accordance to the signal of f igure x.1 the strain rate 
can also be defined as: 
 
Where v2 is the velocity of the second pattern and v1  is the velocity of the 
first pattern. The local instantaneous velocit ies are measured with Doppler. 
 
Figure 5.3 Schematic overview of operations in velocity gradient method 
 
From the strain rate, the strain can be obtained by integration over t ime.  
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5.3 ELASTOGRAPHY WITH MECHANICAL STIMULATION 
 
Elastography with mechanical stimulation or Static Elastography is the most 
frequently used elastography technique. In this application, a compressive 
force is applied to the t issue. The force can be applied either using 
motorized compression f ixtures or using the ultrasound imaging transducer 
itself. The images obtained before and after compression are recorded to 
estimate the local motions using a correlation methods. The estimated 
motion valves along the ultrasound propagation direction represent the axial 
displacement map of the t issue and are used to determine the axial strain 
map. The strain map can then be displayed as a gray scale or colour-coded 
image and is called elastogram.   
 
•  FREE HAND SCANNING 
the simplest approach is to perform compression ultrasound imaging by a 
conventional transducer while applying freehand, periodic, gentle axial 
loading and unloading to the t issues of interest with the same transducer as 
depicted by the arrow in f ig. 5.4 (US2005283076 & US6508768).  
 
Figure 5.4: Free Hand Technique (US2005283076) 
 
In this case the strain imaging capabil i ty may be added to a standard 
cl inical ultrasound platform as a software up-grade without the need of new 
hardware addit ion.   
 In order to obtain a meaningful value of the strain the pressure applied by 
the physician must be known. This information is acquired with pressure 
sensors (WO0139668) located in the transducer housing. 
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Figure 5.5: Ultrasound Array with Pressure Sensors (WO0139668) 
 
The compression of the t issue can also be done by a probe inserted 
percutaneously during catheterization into the t issue to be measured. The 
physician drives the probe in the region of interest and applies the 
compression with the catheter  (EP148502).  The transducer placed in the 
catheter (or alternatively outside) is used for pre and post-compression 
imaging. The scan must be done in a period of minimal periodic 
physiological motion (i.e. breathing). 
 
Figure 5.6 Block Diagram of catheter compression device 
 
 
 
 
 
 
 
 
 
 
 
 
 
 74
 
•  MECHANICAL SCANNING 
The use of devices that provide a mechanical stimulation to the t issue has 
the advantage that the compression intensity can be well controlled. 
The stress is applied by a motorized compression f ixture. Patents and 
patent applications describing this approach include US5107837, 
US6270459, US6514204, WO9746160, US6558324 and  EP0958785.  
 
 
Figure 5.7 block diagram of a mechanical compression systems EP0958785  
 
The differences among these patents are mainly in the construction of the 
apparatus and the display of the results. 
With mechanical stimulation it is also possible to measure biomechanical 
properties of joints and other movable structures of the human body 
(GB2404024) 
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Figure x.8 Schematic diagram of the system for evaluating biomechanical properties of joints 
(GB2404024) 
 
A shaker is used for inducing impulsive stimulation to the target structure. 
More rigid components or target structures, such as bones wil l  be displaced 
according to forces transmitted to them through the surrounding soft t issue, 
which wil l  generally exhibit resil ient elastic or plastic properties. The rigid 
components wil l  reflect any ultrasound pulses directed at them, which 
provides detailed information regarding their precise displacement as a 
function of t ime. In turn, this wil l  reveal information regarding the 
surrounding medium through which the externally generated physical 
displacement excitation has been transmitted. 
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5.4 ELASTOGRAPHY WITH WAVE STIMULATION 
  
The tissue motion can also be induced by a propagating wave. The basic 
principle is to stimulate the t issue with low frequency waves and image the 
region of interest with higher ultrasound frequency pulses. Different types of 
waves can be applied in order to obtain different t issue responses. 
•  LONGITUDINAL WAVE STIMULATION 
In patent US5919139 an audio transducer transmits vibrational energy into 
an area of a subject to be scanned. The vibrational energy transmitted by 
the audio transducer induces palpable vibrations in the t issue medium of the 
area being scanned. Simultaneously an ultrasound transducer transmits 
ultrasound pulses into the area. The amplitude and frequency variance of 
the observed mechanical properties of the t issue are derived from the 
amplitude and frequency variance of the observed vibrations 
 
Figure 5.9: Audio/Ultrasound transducer (US5919139) 
 
The audio transducer and the ultrasound transducer are coupled to each 
other through a duplex probe bracket which holds both transducers and 
allows the audio transducer to be pivoted relative to the ultrasound 
transducer.  
A similar technique is applied in patent US6068597  where a vibration of a 
wide range of frequencies is transmitted to the tissue with an audio 
amplif ier. In this way it is possible to analyze the t issue response for a wide 
spectrum of frequencies and different pathologies can be diagnosed 
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Figure 5.10: transducer assembly (US6068597)  
 
 
AS observed in Ophir et al. (2000) the main application of Elastography is 
tumours investigation. However elastography can also be used for a blood 
vessel and cardiac t issue investigation (US2004167403) .  
A f irst low power (1-10 W/cm^2) tracking pulse is transmitted by the 
transducers to the t issue. After that a pushing pulse of high energy (1000-
10000 W/cm^2) is transmitted by the same transducer and immediately 
afterwards a second tracking signal is sent to the target region.  
 
 
Figure 5.11: Schematic diagram of the system for evaluating blood vessel or cardiac tissue 
(US2004167403)  
 
Comparing the backscattered signal received before and after the pushing 
pulse it is possible to evaluate the mechanical characteristics of the blood 
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vessel or cardiac t issue. This procedure can be repeated sequential ly to 
provide a series of cycles 
When deriving the mechanical propert ies of the medium from US 
observation a model of the t issue is always assumed. An elaborate 
representation of the t issue was proposed in patent application 
US200511956  where different layers of the t issue are modelled as 
separated interconnected elements. 
 
Figure 5.12: Tissue Models for calculate viscoelastic parameters (US2005119568) 
 
The different parameters of the model are then obtained by minimizing the 
error between the real measurement and the calculated model response. 
 
 
Figure 5.13 Schematic of the process 
 
Several models are described and these include representing elements as 
spring & dampers (f ig 5.12 left) or as black boxes where each tissue layer is 
identif ied with a specif ic transfer function (f ig 5.12 right). 
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•  SHEAR WAVE STIMULATION 
 
First described in patent  US5810731  (f i led March 4, 1997), Shear wave 
elasticity imaging (SWEI) is a new approach to imaging and characterizing 
t issue structures based on the use of shear acoustic waves remotely 
induced by the radiation force of a focused ultrasonic beam. 
Transmission of an ultrasound pulse with a conventional transducer 
generates almost exclusively longitudinal waves, i.e. waves in which the 
deformation propagates along the direction of motion of the t issue. However 
a portion of t issue displaced in the axial direction can be itself a "virtual 
source" communicating its movement to the neighbouring portions of t issue 
and inducing a secondary shear wave in the direction orthogonal to the 
propagation of the original wave.   
 
Figure 5.14: shear wave travelling to the right and perpendicular deformation  
http://pubs.usgs.gov 
 
In patent application US200468184  ultrasound energy is transmitted by an 
ultrasound transducer into the t issue in a f irst direction to provide a virtual  
extended shear wave source. The virtual extended shear wave source 
generates an extended shear wave that propagates orthogonally to the f irst 
direction. 
To generate this particular wave the axial component of the shear wave 
source is strengthened by adding another wave with opposite polarity near 
the f irst one.  
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Figure 5.15: Virtual Shear Wave source and shear wave propagation through the tissue US200468184 
 
The ultrasound system can be programmed to excite selected transducer 
elements of the ultrasound transducer array that can generate ultrasound 
energy to provide the virtual extended shear wave source. 
 
 
Figure 5.16: Ultrasound imaging method for tracking the displacement US200468184  
 
 
The displacement of t issue is tracked (receiving reflected ultrasound energy 
from the t issue) by an ultrasound transducer. The ultrasound transducer is 
used to generate the virtual extended shear wave source and, later, the 
same transducer (or another one as shown in f ig. 5.16) is used to track the 
movement of the t issue caused by the propagation of the extended shear 
waves.   
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5.5 ELASTOGRAPHY WITH PHYSIOLOGIC EXCITATION 
 
The mechanical properties of the t issues can be observed exploit ing where 
possible their natural movements instead of stimulating them externally. 
With this technique it is possible to calculate the mechanical parameters of 
organs l ike heart and arteries.  
 
•  CARDIAC STRAIN MEASUREMENTS 
The non-invasive quantif ication of regional myocardial function is an 
important goal in cl inical cardiology. Myocardial thickening/thinning indices 
are one method of attempting to define regional myocardial function 
[D'Hooge et al. 2000].  The basic technique is the same as used for 
elastography with external excitation, i.e. a region of interest is scanned 
before and after compression and signal are post-processed (real t ime or 
off- l ine) for calculating the mechanical indices. Scanning can be performed 
in the apical or parasternal view as shown in f igure 5.17.  
 
Figure 5.17: Apical view (left) and Parasternal view (right)  
http://depts.washington.edu/cvrtc/imgac.html 
 
The scanning posit ion information is important for transformation of data in 
the transducer coordinate system into the heart coordinate system  
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Figure 5.18 Transducer and heart coordinates system 
 
For example, if  a scan is performed in the apical view the axial direction of 
the transducer corresponds to the longitudinal axes in heart coordinates, 
whereas if the scan is performed into parasternal view, the transducer's 
axial direction is the corresponds to the radial direction of the heart. 
 
•  1D Measurement 
In cardiac strain estimation, cross correlation or gradient velocity methods 
described in paragraph x.2 are used to estimate 1D strain along the axial 
direction of the transducer. 
The first approach is presented in patent application US2003113043 and the 
latter in patent and patent applications US2004092766 US6099471, 
WO9917660  
Some devices  provide information about mechanical characteristic in real 
t ime (US2004288989,US6099471)  
•  2D Measurement 
A major drawback of the approaches described above is that they are l imited 
to making only a one-dimensional measurement. Indeed, only the strain 
(rate) along an image l ine can be assessed [D'Hooge et al. 2001].  This 
l imitation causes the technique to be angle dependent [Castro et al 2000].  
As a result the deformation information is incomplete and this could l imits its 
application in quantifying the cardiac function. 
To overcome this l imitat ion a method for calculate longitudinal and radial 
strain rate is described in patent application WO2006124603 and 
EP1079240 .  
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Scanning is performed in the parasternal view. The strain in the radial 
direction (axial of the transducer) is calculated with the velocity gradient 
method, the strain in the longitudinal direction (lateral for the transducer) is 
estimated by tracking the movement of RF patterns from a l ine to another. 
To do this, the scan angle of the transducer is narrow (about 10 degrees) 
and the number of RF image l ines is set at low value (12 images instead of 
60). This allows to have: 
•  Images not much decorrelated in the longitudinal direction 
•  High number of frames per second 
In patent US6527717  motion tracking and Doppler information are used for 
the determination of a two-dimensional motion f ield and it is represented 
with vectors superposed on a B-mode image.  
 
 
Figure 5.19 Motion vectors (US6527717) & www.medical.siemens.com  
Where tissues are moving in different directions within a scanned region, a 
plurality of local determinations of two-dimensional motion vectors provides 
accurate estimates of motion throughout a scan region.  
•  INTRAVASCULAR ULTRASOUND ELASTOGRAPHY 
The composit ion and morphology of the atherosclerotic lesion (i.e. the 
plaque) are considered as an important determinants of acute coronary 
ischemic syndromes. When a lesion is unstable, i t  may rupture and cause a 
thrombosis reaction. A rupture prone-plaque contains a large l ipid pool 
covered by a thin f ibrous cap and intravascular ultrasound elastography has 
been suggested to be a good technique to assess the presence of l ipid 
pools and identify regions of high mechanical stress [De Korte et al. 2002] . 
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Figure 5.20: Vascular elastography measurement procedure [De Korte et  al .  2002]  
 
For intravascular purposes, the intraluminal arterial pressure is used as the 
excitation force (EP1713398).  The radial strain of the t issue is obtained by 
cross-correlation techniques on the radio frequency (RF) signal as already 
describes The strain is colour-coded and plotted as a complimentary image 
to the IVUS echogram. 
 
Figure 5.21: Flowchart of vascular elastography (EP1713398)   
 
The method described in patent application EP1713398 can also be adapted 
using high resolution ultrasound devices for non-invasive vascular 
ultrasound elastography (NIVE) to non-invasively characterize superficial 
vessels such as carotid, femoral arteries, etc. NIVE is of cl inical values for 
the purpose of diagnosis and follow-up of vascular pathologies. The method 
can further be adapted for non-invasive vascular ultrasound micro-
elastography (MicroNIVE) for characterizing small superficial vessels in 
humans and animals. 
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5.6 STATISTICS 
 
Patents about this f ield can be founded in the following classes: 
A61B8/08       .      Detecting organic movements or changes, e.g. tumours, 
cysts 
A61B8/08B     . .   [ N: using Doppler signals (special applications of sonar    
                             systems for mapping or imaging] 
And using the fol lowing key word: 
Z61B8 imaging strain 
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CHAPTER VI 
BLOOD FLOW DOPPLER 
 
 
 
 
 
 
 
 
6.1 INTRODUCTION 
In blood velocity estimation, the goal is not simply to estimate the mean 
target posit ion and mean target velocity. The goal instead is to measure the 
velocity profi le over the smallest region possible and to repeat this 
measurement quickly and accurately over the entire target. Therefore, the 
joint optimization of spatial, velocity, and temporal resolution is crit ical. In 
addit ion to the mean velocity, diagnostically useful information includes the 
volume of blood flowing through various vessels, spatial variations in the 
velocity profi le, and the presence of turbulence. 
The figure below  summarize the environment of an ultrasonic blood 
velocity. 
 
Figure 6.1: Blood Flow measurement environment  
(Handbook of biomedical Engineer, Bronzino J.D. CRC Press. Inc , 2000) 
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The movement of blood cells causes a change in the frequencies of 
reflected sound waves (Doppler effect). If there is no blood flow, the 
frequency does not change. Information from the reflected sound waves can 
be processed by a computer to provide graphs or pictures that represent the 
f low of blood through the blood vessels.  
Current ultrasonic imaging systems operate in a pulse-echo (PE) or 
continuous-wave (CW) intensity mapping modes as explained in chapter 2 
(ultrasound overview). 
As shown in the previous chapters, the Doppler effect is a widely used 
technique in diagnostic ultrasound, there are examples in USCA, 3D imaging 
and Elastography. 
The applications of Doppler effect described in this chapter can be divided 
in 4 category: 
•  Blood flow in vessels and arteries; 
•  Blood flow in the heart ; 
•  Application of Doppler effect in pregnancy; 
•  Transcranial Doppler. 
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6.2 DETECTION OF BLOOD FLOW 
 
A typical Doppler device is described in patent application EP0933063,  the 
ultrasonic echo signals are computed by a phase shift detector (see f igure 
6.1, 30) and the blood stream velocity is calculated. The brighter or darker 
color is displayed according to the blood velocity in the vessel. 
 
Figure 6.1: Blood Flow device  block diagram EP0933063  
 
The information about the blood flow can provide to the physician new 
information about the condit ion of the vessel and the presence of blood 
clots. A method for detecting arterial stenosis is described in patent 
application EP1363539 .  The detection of  blood clots and blocked or 
narrowed blood vessels in almost any part of the body, especially in the 
neck, arms, and legs is a very important information for the physician. 
Blocked or narrowed arteries of the neck can cause dizziness, loss of vision, 
paralysis, weakness, numbness, or other symptoms of a stroke. Blood clots 
in the deep veins of the leg can cause leg pain and swell ing and can 
increase a person's risk of pulmonary embolism.  
To prevent art ifacts caused by the motion of arteries induced by cardiac 
pressures the device is ECG gated as the devices described in  chapter 4 
such as US5871019 and DE19723053 
After selecting a reference point the physician scans a region of interest 
with the transducer. The device is coupled with an articulated arm that 
measures accurately  the relative angle between the reference point and the 
scanner which allows calculation of the velocity.  
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Figure 6.3 Doppler device (EP1363539) 
 
The Doppler ultrasound system detects the velocity profi les of blood flow 
through a selected area of interest and creates a series of velocity profi les 
within the area of interest. These velocity profi les are then used to 
reconstruct the path of the artery and calculate the change of velocity along 
the length of the artery (delta curve). 
 
Figure 6.4 Velocity profiles along the artery (EP1363539) 
 
Certain parameters indicative of potential ly stenotic segments are 
automatically identif ied by analyzing the velocity and the delta curve of the 
segment of the artery. The parameters are: 
•  the average velocity of the velocity profi le; 
•  the peak change in velocity across the velocity profi le;  
•  the presence and degree of blunt f low found in the velocity profi le; 
•  the presence and degree of turbulence found in the velocity profi le;  
•  the degree of skew in the velocity profi le; 
•  the width of the velocity profi le. 
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All these parameters allow to make a diagnosis of a potential ly stenotic area 
as shown in f igure 6.5 
 
 
Figure 6.5 Potential stenotic area (EP1363539) 
 
One problem in measuring blood flow is to calculate the relative angle θ  
between the transducer and the blood direction.  
In patent application EP1693004  this problem is solved by dividing  the 
transducer in two parts, the f irst part sends the signal and the other part 
receives the reflected wave. The computer analyze the reflected signal, 
calculate the shift in frequency and the angle between the incident and 
reflected wave. When all these parameters are obtained it is possible to 
calculate the blood flow velocity. 
 
Figure 6.6 Doppler device (EP1693004) 
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A solution to this problem is also proposed in patent application EP1221895. 
The idea is to divide the transducer in two parts as described in EP1693004 
(f irst patent application described in this chapter) but use each part of the 
transducer to transmit and to receive the ultrasound signals. The angle of 
blood flow or t issue motion is automatically calculated by comparing the 
reflected signals .  
 
Figure 6.7 Doppler device (EP1221895)  
Another solution to the problem of the relative angle is described in patent 
application US2006241459.  The ultrasonic beam is electronically rotated as 
shown in f igure 6.8, thereby enabling to the image of the artery under 
different angle. 
 
Figure 6.8 Doppler transducer (US2006241459) 
 
Furthermore, the device continuously controls the direction of the ultrasound 
beams to achieve maximum return signal amplitude. Then, the condit ion and 
trend of the blood flow of the scanned region is recorded and displayed.  
The same problem is addressed in patent US5844140 .  The transducer is 
mounted in a f luid f i l led housing with a magnetic rotor that al lows to move 
the transducer in the desired posit ion using magnetic coils. Hall effect 
sensors mounted in the housing allow to determine the posit ion of the rotor 
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and of the transducer.   Like in the patent application US2006241459 the 
Doppler signals are analyzed by a computer and the best al ignment is 
automatically calculated    
 
Figure 6.9 Magnetic Driving System (US5844140) 
 
This device can be used for several application  l ike carotid-tracking and 
also for transcranial Doppler ultrasound TCD, that wil l  be described in the 
next section 
The Doppler effect is also used in f irst aid devices l ike defibri l lators as 
described in patent application EP1463562.  The transducer array is 
mounted on an adhesive patch to detect the pulse of the patient in the 
carotid artery. The device is also equipped with ECG detection system. If no 
signal of blood flow and no ECG signal is present the defibri l lator is "armed" 
and it is possible to provide the electrical shock to the patient.  
 
Figure 6.10 Cardiac Resuscitation System with perfusion detection system (EP1463562) 
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Another application of Doppler device is the diagnosis of male impotence. 
The system described in patent US6251076  analyze the blood flow in the 
cavernosal artery of the penis. The housing allows a f ixed orientation with 
respect to the artery while the ultrasound signals are acquired. 
 
Figure 6.11 Male impotence diagnostic system (US6251076) 
 
As widely known, tumours are able to develop a very complex 
vascularisation. By analyzing the type of vascularisation it is possible to 
discriminate a benign tumour from a malignant one, as described in patent 
application WO2005004726.  
After imaging an area where a tumour is present the blood flow is calculated 
and by analyzing the velocity profi les of blood it is possible to calculate the 
vascular resistance to blood flow. If the level of vascular resistance is lower 
than a threshold value the tumour is a malignant, if   is higher the tumour is 
benign (see table, f igure 6.12). 
 
 
Figure 6.12 Values of the parameters which characterize the velocity spectrum  
(WO2005004726) 
 
The availabil i ty of micro and nano-technologies has made possible the 
development of portable devices in the last years, such as watches that can 
provide information of the blood flow as described in patent US6758816 and 
portable device that al lows to measure the blood rheology non invasively 
(US2003032869)  .  
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In patent US6758816  the transducers, a transmitter and a receiver, are 
placed inside the watch strap and they acquire information of blood flow 
during the whole day. The information about f low can be stored and then 
analyzed. 
 
Figure 6.13 Pulse wave watch detector (US6758816) 
 
 
 
In patent application US2003032869 a rheology measuring apparatus is 
described. Rheology is the study of the deformation and flow of a substance 
(blood) under the influence of an applied stress. 
The ultrasound transducers are mounted into a button of a normal pc-
mouse, the blood-flow of the artery in the right(or left) forefinger is analyzed 
before and after clicking the button and the information are analyzed by a 
microprocessor that al lows to calculate the mechanical characteristics of 
blood.    
 
Figure 6.14 Rheology measuring apparatus (US2003032869) 
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6.3 BLOOD FLOW IN THE HEART 
As described in chapter 5 (Elastography) the Doppler effect is widely 
exploited to measure the movement of heart walls. This is not the only 
possible application of Doppler effect in heart diagnosis. By analyzing the 
blood flow inside the chambers of the heart or immediately after i t  leaves 
the aortic valve it is possible to recognize the condit ion of the cardiac 
valves.  
The device described in patent application EP1601291 is a Doppler device 
for monitoring the blood flow through a cardiac valve. By selecting the time 
delay of the signal i t  is possible to obtain information about the blood flow 
immediately after the cardiac valve. The transducer array is placed is so 
that an apical view of the heart is obtained (see figure 6.15). The blood flow 
calculated from the Doppler signals is then visualized and abnormalit ies of 
blood flow caused by diseased condit ion of the cardiac valve are detected. 
 
Figure 6.15 Ultrasonic device for monitoring the condition of flow through a cardiac valve 
(EP1601291) 
 
A cardiac valve that is diseased or defective can be surgically excised and 
replaced with an artif icial valve. 
Once the valve has been replaced, it  wil l  be desirable to carefully monitor 
the condit ion of the valve, to ensure that i t  continues to function properly. 
While it is possible to externally examine a patient and reach diagnosis 
concerning the condit ion of a replacement valve and its proper functionality, 
an external examination may fai l  to identify incipient problems. If the valve 
subsequently fai ls catastrophically, the patient may die before surgery can 
correct the problem. 
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To prevent this event a system for monitoring the condit ion of f low through a 
cardiac valve is described in patent US6398734. 
The ultrasound transducer are built  with f lexible piezoelectric material that 
al lows to mount the transducers or within the wall of an artif icial cardiac 
valve or around a cuff that wraps around aorta. The blood flow is 
continuously monitorized and if some abnormalit ies are revealed the device 
can send an alarm signal to a computer or to a cell phone . 
 
Figure 6.16 Ultrasonic device for monitoring the condition of flow through a cardiac valve 
(US6398734) 
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6.4 DOPPLER EFFECT IN PREGNANCY 
An important information that can be obtained with the Doppler effect is the 
heartbeat frequency of fetus. It is known that heartbeat frequency of a fetus 
is higher than the frequency of the mother, and this difference in 
frequencies is exploited for calculate the fetal heartbeat rate in patent 
US5630418.   
The Doppler signal that is received by the transducer contains components 
of the frequencies from the mother (low frequencies) and from the fetus 
(high frequencies), the signal is f i ltered with an high-pass f i l ter which 
eliminates the low frequencies and the fetal heart rate is calculated by 
Fourier transform.  
Another method for the calculation of the heartbeat frequency is presented 
in patent application DE10345717 .  The process comprises 3 steps: 
1) The coefficient of the frequency of harmonic analysis of the signal at a 
certain t ime is calculated for several periods; 
2) The Auto-correlation function of the previous coefficients is determined; 
3) The fetal heartbeat frequency is calculated from the posit ion of the 
maximum of the auto-correlation function obtained in the second step. 
 
Figure 6.17 Detection of fetal heartbeat frequency (DE10345717) 
 
 
 
 
 
 
 98
6.5 TRANSCRANIAL DOPPLER ULTRASOUND (TCD) 
Transcranial Doppler (TCD) ultrasound is a non-invasive method for the 
estimation of the blood flow velocit ies in the intracranial vessels. Using 
established TCD techniques, sections of the internal carotid artery (ICA), 
middle cerebral artery (MCA), anterior carotid artery (ACA), posterior 
cerebellar artery (PCA) and the basilar and periorbital arteries can be 
examined [Markus 1993] . TCD typically uses a 2 MHz pulse ultrasound 
posit ioned as shown in f igure 6.18 
 
Figure 6.18 Positioning of the transducer in a  TCD examination  
http://www.mcg.edu/neurology 
 
A TCD system is described in patent application US2002103436 .  The 
system comprise a bi-temporal probe hanger where the transducers are 
mounted as shown in f igure 6.19  
 
Figure 6.19 Bi-temporal probe hanger (US2002103436) 
  
The ultrasound transducers are placed on the skin overlying the temporal 
bone (temple). The ultrasound transducer is connected with 2 rol ler balls 
that allow the physician to t i lt  the transducers in the desired direction as 
shown in f igure x.18. 
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Figure 6.20 Probe Housing (US2002103436) 
  
The intensity of the reflecting waves can be used for detecting circulating 
emboli,  in fact the proportion of ultrasound reflected at the interface 
between two materials, such as that between blood and an embolus, is 
proportional to the difference in acoustic impedances of the two materials. 
Acoustic impedance itself depends on density; therefore, the greater the 
difference in density between the two media, the greater the amount of 
ultrasound reflected, and the greater the intensity of the received signal. 
A crucial point in the diagnosis of thromboembolic event is the t ime between 
the diagnosis and the administration of l i fe-saving thrombolityc therapy. The 
system described in patent US6486219 is an implantable transcranial 
Doppler device with a drug delivery system connected with an external 
handheld computer. This device can be implanted in patients with high risk 
of stroke. 
 
Figure 6.21 Implantable doppler device for TCD (US6486219) 
  
The ultrasound transducer is placed in a f lexible si l icone probe housing. The 
housing contains also a reservoir for the therapy drug. 
The analysis of the Doppler signals is done by the handheld computer that 
is telemetric connected with the transcranial Doppler device. Some 
threshold parameters(e.g. f low velocity) are configured in order to allow 
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automatic diagnosis and if  a  an emboli is detected the computer sends a 
signal to the implantable device to cause the infusion of thrombolityc and 
neuroprotective agents into the vein of the patient.  
 
 
Figure 6.22 Implantable probe with drug delivery pump (US6486219) 
 
The height of the probe housing is chosen such that i t  does not protrude 
sideways to alter the side profi le of the patient's head and is well within the 
area covered by the hairl ine no cosmetic defect are produced by the 
implantation of the probe housing. 
With TCD it is also possible to monitor the intracranial pressure (ICP). 
Elevated intracranial pressure not only reduces blood flow to the brain, but 
it also affects the normal metabolism of cells within the brain. Under some 
condit ions, elevated intracranial pressures may cause the brain to be 
mechanically compressed, and to herniate. Before the TCD technique the 
conventional ICP monitoring devices were epidural catheters, subarachnoid 
screws and ventriculostomy catheters. All of these methods are invasive and 
must be performed in hospitals.  
 
Figure 6.23 Invasive TCP measurement 
 http://www.pennhealth.com 
 
With the device described in patent application US2006079773  non invasive 
ICP measurements are possible thanks to the application of elastography to 
TCD.  
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Figure 6.24 TCD for monitoring ICP (US2006079773)  
 
The general principle of this technique is the similar as in elastography 
5. Acquiring a pre compression ultrasound image of the region of interest 
(Brain); 
6. Applying compression to the tissue with high power ultrasound pulse; 
7. Acquiring a post compression relaxing signals of the same region; 
8. Evaluating the ICP of the same region by analyzing the post 
compression relaxing signal as shown in f igure 6.25 
 
 
Figure 6.25 Procedure for monitoring ICP with TCD (US2006079773)  
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6.6 STATISTICS 
 
Patents about this f ield can be founded in the following classes: 
A61B8/02             .  Measuring pulse or heart rate 
A61B8/02B            . .   (186)   [N: of a foetus] 
A61B8/06             .  Measuring blood flow 
A61B8/06B           .  .   [N: to determine blood output from the heart] 
A61B8/06F            . .  [N: combined with B-scan, e.g. tomography] 
A61B8/08P            . .    [N: Devices for detecting pregnancy] 
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CHAPTER 7 
ULTRASOUND CATHETERS 
 
 
 
 
 
 
 
 
 
 
 
7.1 INTRODUCTION 
Miniaturization is a cont inuing trend in technology toward ever-smaller 
scales for f irst mechanical, then optical and most recently electronic 
devices. 
In the last year also ultrasound devices have exploited this trend in 
technology and ultrasound catheters started to be ut i l ized in hospitals. The 
major advantage of the use of ultrasound catheters is that it  is possible to 
uti l ize higher frequencies because a deep penetration of the beam is not 
necessary. Thanks to the use of higher frequencies higher axial resolution is 
reached. 
Ultrasound catheters can be uti l ized for trans-esophageal echography 
(TEE), intravascular ultrasound (IVUS) and trans-rectal echography. 
Their application range is very wide, from 3D imaging of organs (chapter x, 
par. 6), to special technique such as vascular elastography (chapter x, par. 
5) and tissue ablation visualization with USCA (chapter x, par. 4). 
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One of the most important characteristic of a catheter is the handiness, 
some solution are provided in order to drive the catheter or at least the 
ultrasound transducer inside the body. 
 
7.2 MECHANICAL ROTATION OF ULTRASOUND CATHETERS 
In mechanical catheters the ultrasound transducer is coupled with a 
mechanical driving system that al lows the physician to rotate, t i l t  or 
translate the transducer. As shown in f igure x.1 the surgeon rotates the 
endoscope shaft (that is inside the body) by turning the control wheel 
(US2004176691)   
 
Figure 7.1 Ultrasound catheter (US2004176691)  
 
A similar solution is proposed in patent application EP0580304 the catheter 
is mechanically t i lted by a mechanical motor driven by the surgeon and the 
3 transducers (A,B,C) can be rotated  as shown in f igure x.2 in order to 
obtain a wider f ield of view 
 
Figure 7.2 Ultrasound catheter (EP0580304)  
 
In patent application EP1691690  once that the catheter reached the desired 
posit ion the transducer can be mechanically moved in order to obtain 
different views of the organ investigated. 
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Figure 7.3 Ultrasound catheter (EP1691690)  
 
 
7.3 MECHANICAL ROTATION OF ULTRASOUND TRANSDUCER 
The same results obtained by rotating the whole catheters can be reached 
by rotating only the distal end of the probe or at least the transducer. 
In patent application DE4207577 the 1D array is mechanically rotated as 
shown in f igure 7.3. The cone beam obtained by rotating the array can be 
used to perform 3D images  
 
Figure 7.4 Ultrasound catheter (DE4207577)  
 
In patent application EP1208801  the probe is equipped with a curvil inear 
array mounted on the distal end of the catheter. The array is l inked to a 
mechanical motor that allows to t i l t  it  as shown in f igure x.5 
 
Figure 7.5 Transducer array and mechanical tilt system mounted in the distal end of a probe 
(EP1208801)  
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Similar solution are proposed in patent application EP1535574 where the 
transducer array is connected to a system of cables (Driving Cable) that 
al lows the rotation. 
 
Figure 7.6 Catheters mechanical driving system (EP1535574)  
A different solution is provided in patent application EP1659951 .  The array 
and the probe are f ixed, the only part that is mechanically rotated is a mirror 
that reflects the ultrasonic wave in the desired direction (f ig. x.7) 
 
Figure 7.7 Catheter with mirror (EP1208801)  
 
I t  is possible also to rotate only the last part of the catheter as shown in 
patent application DE19926708 .  This particular catheter is also equipped 
with a channel for delivering drugs or USCA into the field of view of the 
catheter. 
 
Figure 7.8 Catheter with fluid channel (DE19926708) 
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7.4 OTHER SOLUTIONS 
 
2D (two-dimensional) images typically do not provide desired accuracy of 
structures/features within a body. In applications where a relatively high 
level of imaging accuracy may be crit ical, such as biopsy needle guidance 
through or in proximity to sensit ive bodily structures which may need to be 
avoided by the needle, l inear array transducer probes may not be practical. 
In patent application  EP0955010 a "biplane" ultrasound catheter is 
described, this catheter is equipped with 2 transducers array mounted in the 
distal end of the probe in order to obtain 2 perpendicular imaging planes   
 
Figure 7.9 Biplane ultrasound catheter (EP0955010)  
 
The biplane ultrasound catheter can also be equipped with a puncture 
needle for performing biopsy as shown in patent US6238336.  
 
 
Figure 7.10 Biplane ultrasound catheter with needle (US6238336)  
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Also catheters with one transducer array can also be equipped with a 
puncture needle for performing biopsy(US6149598 ).  See f igure x.11 
 
Figure 7.11 Ultrasound Catheter with needle (US6238336)  
 
In patent application EP1059878  an optical-acoustic imaging catheter is 
described. The device comprises a single-mode optical f iber with a Bragg 
grating surrounded by a piezoelectric jacket in polyvinyldiene fluoride 
(PDVF). 
An electrical generator transmits ultrasound impulses to both the Bragg 
grating and to the t issue where the catheter is located, e.g. the blood. The 
backward signal causes deformation in the PDVF jacket, and also in the 
Bragg grating. 
If mechanical deformations appear inside the optical f iber, they cause 
modulation of l ight reflected backward, which is received by the electronic 
instruments. 
 
Figure 7.10 Optical acoustic imaging catheter (EP1059878) 
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7.5 MINIMALLY INVASIVE CATHETERS 
 
A l imitation of al l  the catheters is that the surgeon does not have tacti le 
sense of the surgical f ield. This l imitation can be exceed with the f ingertip 
ultrasound medical instrument described in patent application  EP1596717, a 
minimal invasive ultrasound surgical instrument mounted on the surgeon's 
f ingertip. The device is also equipped with a pressure sensor (f ig x.11) 
 
Figure 7.11 Fingertip ultrasound device (EP1596717) 
 
A similar solution is proposed also in patent application WO0165537 .  The 
miniaturized ultrasound transducer (f ig 7.12) is mounted at distal end of the 
f lexible cable (f ig. 7.12)  
 
Figure 7.12 Miniaturized catheter  (EP1596717) 
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The less invasive catheter is described in patent application EP1529483. 
The capsule endoscope can be swallowed by the patient and then naturally 
ejected. The transducer can be rotated without causing rotation in the 
capsule. This allows to image all the digestive system without introducing a 
trans esophageal catheter inside the patient. 
 
Figure 7. 13 capsule endoscope  (EP1529483) 
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7.6 Statistics about ultrasound catheters 
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CHAPTER IIX 
CONCLUSIONS 
 
 
 
 
 
 
 
 
 
 
 
After having analyzed a vast number of patents and patent application it is 
possible to indicate the future trends in the f ield of diagnostic ultrasound. 
What is possible to see is that there is a trend toward miniaturization and to 
telemedicine, the term telemedicine is the delivery of medicine at a 
distance. The necessity to have small portable devices that allow checking 
the patient’s condit ion even at home is one of the future direction of develop 
of this technology. As cited in patent and patent applications US6390979 ,  
US2003225335 and DE20318977  the device for monitor and analyze blood 
flow are connected wireless with the cell-phone of the patient and they can 
send an alarm to a caregiver if the signal presents some abnormalit ies.   
Monitoring a patient at home using known devices l ike blood flow monitors 
and transferring the information to a caregiver is a fast growing emerging 
service. These remote monitoring solutions has a focus on current high 
morbidity chronic diseases. 
The miniaturization of components in recent years has made possible to 
create portable device that provide an overall solution in terms of 
ergonomics, ease of use by those having l imited experience with ultrasound 
diagnostic equipment, imaging acquisit ion and processing capabil i ty, image 
display quality, and user localization, such as watches that can provide 
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information of the blood flow and portable imaging device l ike the system 
described in patent US6436040.  
Thanks to the miniaturizat ion of components, ultrasound catheters started to 
be used in hospitals. The major advantage of the use of ultrasound 
catheters is that i t  is possible to scan the region of interest with high 
frequencies because a deep penetration of the beam is not necessary. 
Thanks to the use of higher frequencies higher axial resolution is reached. 
Ultrasound catheters can be uti l ized for trans-esophageal echography 
(TEE), intravascular ultrasound (IVUS) and trans-rectal echography. 
As described in chapter 7, now it is possible to have minimally invasive 
catheters such the one described in patent application EP1596717  and the 
capsule endoscope described in patent application EP1529483 ,  that al low to 
have images  of the gastrointestinal tract. The Natural peristalsis moves the 
capsule endoscope smoothly and painlessly throughout the gastrointestinal 
tract. 
In the next future, 3D ultrasound imaging wil l  represents the highest level of 
us technology. With these device it is possible to obtain new views and a 
whole organ approach allows to quantify without l imitations some important 
parameters l ike the volume etc. 
At the moment, these device are not very expanded due to the high cost and 
the fact that the new information provided must be validated before these 
device wil l  be very common in hospitals. The only application of these 
device at the moment is to obtain 3D images of the foetal. The increasing 
number of patent application in this f ield al lows to aff irm that in the next 
years these device wil l  be common in hospitals. 
Another recent application of ultrasound is the elastography. The different 
mechanical characteristic of the tumour's t issue from the surrounding tissue 
is the basic principle of palpation. However, a lesion, in the prostate or in 
the breast in particular, may or may not possess echogenic properties and it 
would be diff icult to detect it  with conventional diagnostic ultrasound 
imaging systems. The imaging modality that facil i tates the display of 
mechanical properties of biological t issue is called elastography and is a 
sort of evolution of the palpation technique. 
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The purpose of elastography is to display an image of the distribution of a 
physical parameter related to the mechanical properties of the t issue for 
cl inical applications.  
Finally, after having analyzed the number of European patent application in 
the diagnostic ultrasound field from 1980 until  2006 we observe a posit ive 
trend, especially in the f ield of 3D imaging. 
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ANNEX 1: Ultrasound contrast agents 
 
Annex to ultrasound contrast agent patent applications statistic.  
OPEN INTERNAL 
    . . f i epodoc 
      
  Selected f i le: EPODOC   
      
  Search statement  1   
      
  ep/pn 
  ** SS 1: Results 1.723.429   
      
  Search statement  2   
      
   . . l im 1 
  ** SS 2: Results 1.723.429   
  Search limited to 1723429 documents   
  Limitation start ing with SS  2   
      
Search statement  3   
      
  ?  ultrasound 
  ** SS 3: Results 1.642   
      
MOVE TO X-FULL (run with the l imitation) 
 
Query : (contrast) 5d (agent or microbubble)  
 
299 document selected 
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Save the Xfi le and go back to internal 
 
110 documents avaible in internal,  
 
Limitation active now on this 110 documents, start the classif ication by 
priority date: 
  ?  pd<1980-01-01 
  **  SS 29: Resul ts  0  
      
  unt i l :  
 
      
  Search statement 51   
      
  ?  pd<2006-01-01 
  **  SS 51: Resul ts  101   
      
  Search statement 52   
      
  ?  pd<2007-01-01 
  **  SS 52: Results  110  
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ANNEX 2: Three Dimensional Ultrasound. 
Above are shown the search procedures for f ind the documents used in my 
state of the art investigation.  
 
1st research 
 
internal 
.. f i epodoc 
ultrasound & tomography 
pd>2000-01-01 
 
90 reusults send to the viewer,10 patents application selected in the drawer 
after reading tit le and abstract of the invention of al l 90 results 
 
 
 
2nd research 
 
internal 
.. f i epodoc 
ultrasound 
pd>2000-01-01  
.. l im 3 (ultrasound & pd)  (9183 results) 
move to x full  (run with l imitation) (al l databases avaible selected) 
Query: (three or 3 or dimension) 3d (scanner or tomography) 
 
75 results send to the viewer,12 patents application selected in the drawer 
after reading tit le and abstract of the invention of al l 75 result 
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3rd research (mechanical scanners) 
 
internal 
.. f i epodoc 
ultrasound 
pd>2000-01-01  
.. l im 3 (ultrasound & pd)  (9183 results) 
move to x ful l (run with l imitation) (al l databases avaible selected) 
Query: (Three or 3 or dimension) 3d (mechanical or scanner) 
 
112 results send to the viewer,11 patents application selected in the drawer 
after reading tit le and abstract of the invention of al l 112 results 
 
 
 
 
 
 
4th research (free hand) 
 
internal 
.. f i epodoc 
ultrasound 
pd>2000-01-01 
.. l im 3 (ultrasound & pd)  (9183 results) 
Free 2d hand  
 
9 results send to the viewer,1 patents application selected in the drawer 
after reading tit le and abstract of the invention of al l 9 results 
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5th research (Catheters and Probes with 3D US) 
 
internal 
.. f i epodoc 
ultrasound 
pd>2000-01-01 
.. l im 3 (ultrasound & pd)   (9183 results) 
move to x full  (run with l imitation) (al l databases avaible selected) 
Query: (catheter or probe) 3d (volum+ or tomograph+ or three or dimension) 
 
80 results send to the viewer, patents application selected in the drawer 
after reading tit le and abstract of the invention of al l 80 results 
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ANNEX 3 ELASTOGRAPHY  
 
Search 1 
Internal: 
. . f i epodoc 
      
Selected fi le: EPODOC   
     Search statement  1   
      
ultrasound 
SS 1: Results 16.176   
      
X-full  
Query: Elastography 
 
70 results send to viewer 
 
Search 2 
Internal 
.. f i epodoc 
    
Selected fi le: EPODOC   
     Search statement  1   
      
ultrasound 
SS 1: Results 16.176   
      
X-full  
Query: (cardiac or myocardial) 3d strain  
22 Documents send to viewer, 
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Search 3 
Internal 
..fi epodoc 
    
Selected file: EPODOC   
     Search statement  1   
      
z61b5/kw      
  ** SS 1: Results 30.872 
 
X-full 
Query: elastography 
36 Documents send to viewer, 
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ANNEX 4: BLOOD FLOW DOPPLER 
 
 
Patents about this f ield can be founded in the following classes: 
A61B8/02             .  Measuring pulse or heart rate 
A61B8/02B            . .   (186)   [N: of a foetus] 
A61B8/06             .  Measuring blood flow 
A61B8/06B           .  .   [N: to determine blood output from the heart] 
A61B8/06F            . .  [N: combined with B-scan, e.g. tomography] 
A61B8/08P            . .    [N: Devices for detecting pregnancy] 
 
 
I used a limitation in the database by publication date: 
 
pd>2000-01-01 
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ANNEX 5: STATISTICS 
All the information used in the statistics at the end of each chapter are 
found in the EPODOC database. 
For the statistics the database is l imited to the European Patent Application. 
After l imited the database to the interesting patents I started the 
classif ication by priority date: 
 
  ?  pd<1980-01-01 
  ** SS 1: Results xx 
      
  unti l :  
 
      
  Search statement 26   
      
  ?  pd<2006-01-01 
  ** SS 26: Results xx   
      
  Search statement 27  
      
  ?  pd<2007-01-01 
  ** SS 27: Results xx  
 
 
•  Chapter 2: Statistics about A61B8/00 
All the European patent application classif ied as A61B8/00, diagnosis 
using ultrasonic, sonic or infrasonic waves. 
            
•  Chapter 3: Statistics about ULTRASOUND CONTRAST AGENTS 
All the European patent application classif ied as A61B8/00D, Diagnosis 
using ultrasonic, sonic or infrasonic waves by tracers, e.g. microbubbles 
introduced into the bloodstream. 
 
•  Chapter 4: Statistics about 3D IMAGING  
All the European patent application classif ied as A61B8/13, Tomography; 
A61B8/14, Echo-tomography; A61B8/15, transmission-tomography. 
All the European patent application with the KEY WORD: Z61B8 imaging 
three dimensional. 
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•  Chapter 5: Statistics about ELASTOGRAPHY 
All the European patent application classif ied as A61B8/08, Detecting 
organic movements or changes, e.g. tumours, cysts; A61B8/08B Detecting 
organic movements using Doppler signals special applications of sonar 
system for mapping or imaging. 
All the European patent application with the KEY WORD: Z61B8 imaging 
strain. 
 
•  Chapter 6: Statistics about BLOOD FLOW DOPPLER 
All the European patent application classif ied as A61B8/02, Measuring 
pulse or heart rate; A61B8/02B Measuring pulse or heart rate of a foetus;  
A61B8/06, Measuring blood flow; A61B8/06B Measuring pulse or heart rate 
to determine blood output from the heart; A61B8/06F Measuring pulse or 
heart rate combined with B-scan, e.g. tomography; A61B8/08P, Measuring 
pulse or heart for detecting pregnancy. 
 
•  Chapter 6: Statistics about ULTRASOUND CATHETHERS 
All the European patent application classif ied as A61B8/06D, imaging of 
objects using sonar in body cavit ies or body tracts by using a catheter. 
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ANNEX 6: ECLA, Main-group A61B8 
According to the ECLA classif ication system all the patents about diagnosis 
using ultrasound are classif ied in the sub-class A61B8. In this annex the 
hierarchical structure of the patent classif ication system is showed. 
 
SECTION: 
 
CLASS: 
 
SUBCLASS: 
 
MAIN GROUP 
 
 
All the patent cited in this work can be classif ied in one of the following sub-
groups. The classif ication is divided in two tables. 
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GLOSSARY 
 
Acoustic impedance: In an analogy to transmission l ine impedance, the 
acoustic impedance is the ratio of pressure to particle velocity in a medium; 
more commonly, i t  is defined as Z=ρc,  where ρ=density and c=speed of 
sound in a medium [the units are kg/(m2 ·sec) or Rayls]. 
 
A-mode: The original display of ultrasound measurements, in which the 
amplitude of the returned echoes along a single l ine is displayed on an 
oscil loscope. 
 
Angular response: The radiation pattern versus angle for a single element 
of an array. 
 
Attenuation: The reduction of signal amplitude that occurs per unit distance 
travelled. Some attenuation occurs in homogeneous media such as water 
due to viscous heating and other phenomena, but that is very small and is 
usually taken to be negligible over the 10- to 20-cm distances typical of 
imaging systems. In inhomogeneous media such as soft t issues, the 
attenuation is much higher and increases with frequency. The values 
reported for most soft t issues l ie around 0.5 dB/cm/MHz. 
 
Axial resolution: The abil i ty to distinguish between targets aligned in the 
axial direction (the direction of acoustic propagation). 
 
Azimuth dimension: The lateral dimension that is along the scanning plane 
for an array transducer. 
 
Backscatter: That part of a scattered signal that goes back toward the 
transmitter of the energy. 
 
Baseband signal: The received signal after the center frequency 
component (carrier frequency) has been removed by demodulation. 
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B-mode or 2D: The current display mode of choice. This is produced by 
sweeping the transducer from side to side and displaying the strength of the 
returned echoes as bright spots in their geometrically correct direction and 
distance. 
 
Carrier frequency: The center frequency in the spectrum of the transmitted 
signal. 
 
Clutter: An unwanted fixed signal component generated by stationary 
targets typically outside the region of interest (such as vessel walls). 
 
Complex envelope: A signal expressed by the product of the carrier, a 
high-frequency component, and other lower-frequency components that 
comprise the envelope. The envelope is usually expressed in complex form. 
 
CNR:  Contrast signal to Noise Ratio. This gives the ratio of the signal power 
scattered from the contrast agent in a region to the noise power in that 
region. This ratio is often referred to as sensit ivity. 
 
CTR:  Contrast signal to Tissue signal Ratio. This gives the ratio of the 
signal power scattered from the contrast agent in a region to the signal 
power scattered from the t issue in that region. This ratio is often referred to 
as specif icity. 
 
Electrical matching networks: Active or passive networks designed to tune 
out reactive components of the transducer and/or match the transducer 
impedance to the source and receiver impedance. 
 
Elevation dimension: The lateral dimension that is perpendicular to the 
scanning plane for an array transducer. 
 
Grating lobes: Undesirable artefacts in the radiation pattern of a 
transducer; they are produced at a location where the path length difference 
to adjacent array elements is a multiple of a wavelength. 
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Heart Coordinate System: The radial (R) axis: perpendicular to the 
epicardium. 
The longitudinal (Lo) axis: perpendicular to the radial axis, tangent to the 
epicardium. The circumferential (C) axis: perpendicular to both the radial 
and longitudinal axis. Figure G.1 i l lustrates the coordinate system. 
 
Figure G.1:  Heart Coordinate System [D'Hooge et  al .  2000]  
 
Lateral modes: Transducer vibrations that occur in the lateral dimensions 
when the transducer is excited in the thickness dimension. 
 
Lateral resolution: The abil i ty to distinguish between targets in the azimuth 
and elevation dimensions (perpendicular to the axial dimension). 
 
Maximum likelihood: A statist ical estimation technique that maximizes the 
probabil ity of the occurrence of an event to estimate a parameter. ML 
estimate is the minimum variance, unbiased estimate. 
 
M-mode: Followed A-mode by recording the strength of the echoes as dark 
spots on moving l ight-sensit ive paper. Objects that move, such as the heart, 
caused standard patterns of motion to be displayed, and a lot of diagnostic 
information such as valve closure rates, whether valves opened or closed 
completely, and wall thickness could be obtained from M-mode recordings. 
 
Real-time imaging: A real t ime image is a digital image in which all the 
operations to the signal are made between two acquired samples. 
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Reflection: Occurs at interfaces between large regions (much larger than a 
wavelength) of media with differing acoustic propert ies such as density or 
compressibil i ty. This is similar to the reflection of l ight at interfaces and can 
be either total, l ike a mirror, or partial, l ike a half-silvered mirror or the 
ghostl ike reflection seen in a sheet of glass. 
 
Scattering: Occurs when there are irregularit ies or inhomogeneit ies in the 
acoustic properties of a medium over distances comparable with or smaller 
than the wavelength of the sound. Scattering from objects much smaller 
than a wavelength typically increases with frequency (the blue-sky law in 
optics), while that from an object comparable to a wavelength is constant 
with frequency (why clouds appear white). 
 
Strain:  Deformation of an object normalized to its original shape. The 
symbol used for strain is ε   and can be written as:  
 
With L  (t) the length of the object at t ime instance t  and L  (t0)  =L0 its init ial 
length.  
 
Strain Rate: Speed at which deformation (i.e. strain) occurs. It  is 
represented by the symbol ε '  and has the unit 1/s.  The instantaneous strain 
rate can be calculated as: 
 
With L ' (t) the rate of deformation and L  ( t) the instantaneous length of the 
object. 
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Ultrasound Coordinate System: The ultrasound coordinate system has 
axial, lateral and elevation axes which are, respectively, along the image 
l ine, perpendicular to image l ine and within the image plane and 
perpendicular to the image plane l ike shown in f igure G.2. 
 
Figure G.2 Ultrasound Coordinate System [D'Hooge et  al .  2000]  
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Patent organization glossary 
AIPLA – American Intellectual Property Law Association 
ASEAN – Association of South East Asian Nations 
ANASE – Association des nations de l ’Asie du Sud-Est 
CIS – Commonwealth of Independent States 
GUS – Gemeinschaft Unabhängiger Staaten 
CEI  – Communauté des Etats indépendants 
EAPIC – Europe-Asia Patent Information Conference 
EAPO  – Eurasian Patent Organization 
EPC – European Patent Convention 
EPI – Institute of Professional Representatives 
EPLA – European Patent Lit igation Agreement 
EUROTAB – European Round-Table on Patent Practice 
IPC – International Patent Classif ication 
IPO – Intellectual Property Owners Association 
JIPA  – Japan Intellectual Property Association 
JPO– Japan Patent Office 
OAPI – Organisation africaine de la propriété intellectuelle  
OHIM  – Office for Harmonization in the Internal Market 
HABM  – Harmonisierungsamt für den Binnenmarkt 
OHMI – Office de l ’harmonisation dans le marché intérieur 
OMPI – Organisation Mondiale de la Propriété Intellectuelle 
PATINNOVA – European Commission conference on patents and innovation 
PCT  – Patent Cooperation Treaty 
Rospatent – Russian Agency for Patents and Trademarks 
SACEPO  – Standing Advisory Committee before the EPO 
SCP – Standing Committee on the Law of Patents 
SIPO – State Intellectual Property Office (Chinese Patent Office) 
SPLT – Substantive Patent Law Treaty 
UNICE  – Union of Industrial and Employers’ Confederations of Europe 
USPTO – United States Patent and Trademark Office 
WIPO – World Intellectual Property Organization 
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